Upload folder using huggingface_hub
Browse filesThis view is limited to 50 files because it contains too many changes.
See raw diff
- .gitattributes +1 -0
- downloads_2025_onwards_2/1018368_2025-02-27_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_485BPOS/1018368_2025-02-27_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_485BPOS_abgrifi-20250227.htm +129 -0
- downloads_2025_onwards_2/1018368_2025-02-27_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_485BPOS/1018368_2025-02-27_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_485BPOS_abgrifi-20250227.pdf +0 -0
- downloads_2025_onwards_2/1018368_2025-02-27_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_485BPOS/images/page_1.png +3 -0
- downloads_2025_onwards_2/1018368_2025-03-04_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_497J/1018368_2025-03-04_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_497J_d11619892_497-j.htm +108 -0
- downloads_2025_onwards_2/1018368_2025-03-04_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_497J/1018368_2025-03-04_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_497J_d11619892_497-j.pdf +0 -0
- downloads_2025_onwards_2/1018368_2025-03-04_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_497J/images/page_1.png +3 -0
- downloads_2025_onwards_2/1018592_2025-01-27_AB_INSTITUTIONAL_FUNDS_INC_485BPOS/1018592_2025-01-27_AB_INSTITUTIONAL_FUNDS_INC_485BPOS_abgifi-20250127.htm +129 -0
- downloads_2025_onwards_2/1018592_2025-01-27_AB_INSTITUTIONAL_FUNDS_INC_485BPOS/1018592_2025-01-27_AB_INSTITUTIONAL_FUNDS_INC_485BPOS_abgifi-20250127.pdf +0 -0
- downloads_2025_onwards_2/1018592_2025-01-27_AB_INSTITUTIONAL_FUNDS_INC_485BPOS/images/page_1.png +3 -0
- downloads_2025_onwards_2/1018840_2025-01-13_ABERCROMBIE__FITCH_CO_DE_8-K/1018840_2025-01-13_ABERCROMBIE__FITCH_CO_DE_8-K_anf-20250113.htm +129 -0
- downloads_2025_onwards_2/1018840_2025-01-13_ABERCROMBIE__FITCH_CO_DE_8-K/1018840_2025-01-13_ABERCROMBIE__FITCH_CO_DE_8-K_anf-20250113.pdf +0 -0
- downloads_2025_onwards_2/1018840_2025-01-13_ABERCROMBIE__FITCH_CO_DE_8-K/images/page_1.png +3 -0
- downloads_2025_onwards_2/1018840_2025-03-06_ABERCROMBIE__FITCH_CO_DE_8-K/1018840_2025-03-06_ABERCROMBIE__FITCH_CO_DE_8-K_anf-20250305.htm +129 -0
- downloads_2025_onwards_2/1018840_2025-03-06_ABERCROMBIE__FITCH_CO_DE_8-K/1018840_2025-03-06_ABERCROMBIE__FITCH_CO_DE_8-K_anf-20250305.pdf +0 -0
- downloads_2025_onwards_2/1018840_2025-03-06_ABERCROMBIE__FITCH_CO_DE_8-K/images/page_1.png +3 -0
- downloads_2025_onwards_2/1018840_2025-03-31_ABERCROMBIE__FITCH_CO_DE_10-K/1018840_2025-03-31_ABERCROMBIE__FITCH_CO_DE_10-K_anf-20250201.htm +129 -0
- downloads_2025_onwards_2/1018840_2025-03-31_ABERCROMBIE__FITCH_CO_DE_10-K/1018840_2025-03-31_ABERCROMBIE__FITCH_CO_DE_10-K_anf-20250201.pdf +0 -0
- downloads_2025_onwards_2/1018840_2025-03-31_ABERCROMBIE__FITCH_CO_DE_10-K/images/page_1.png +3 -0
- downloads_2025_onwards_2/1023731_2025-01-16_8X8_INC_DE_4/1023731_2025-01-16_8X8_INC_DE_4_wk-form4_1737062003.html +287 -0
- downloads_2025_onwards_2/1023731_2025-01-16_8X8_INC_DE_4/1023731_2025-01-16_8X8_INC_DE_4_wk-form4_1737062003.pdf +0 -0
- downloads_2025_onwards_2/1023731_2025-01-16_8X8_INC_DE_4/images/page_1.png +3 -0
- downloads_2025_onwards_2/1023731_2025-02-04_8X8_INC_DE_8-K/1023731_2025-02-04_8X8_INC_DE_8-K_eght-20250204.htm +129 -0
- downloads_2025_onwards_2/1023731_2025-02-04_8X8_INC_DE_8-K/1023731_2025-02-04_8X8_INC_DE_8-K_eght-20250204.pdf +0 -0
- downloads_2025_onwards_2/1023731_2025-02-04_8X8_INC_DE_8-K/images/page_1.png +3 -0
- downloads_2025_onwards_2/1023731_2025-02-05_8X8_INC_DE_10-Q/1023731_2025-02-05_8X8_INC_DE_10-Q_eght-20241231.htm +129 -0
- downloads_2025_onwards_2/1023731_2025-02-05_8X8_INC_DE_10-Q/1023731_2025-02-05_8X8_INC_DE_10-Q_eght-20241231.pdf +0 -0
- downloads_2025_onwards_2/1023731_2025-02-05_8X8_INC_DE_10-Q/images/page_1.png +3 -0
- downloads_2025_onwards_2/1023731_2025-02-11_8X8_INC_DE_144/1023731_2025-02-11_8X8_INC_DE_144_primary_doc.html +140 -0
- downloads_2025_onwards_2/1023731_2025-02-11_8X8_INC_DE_144/1023731_2025-02-11_8X8_INC_DE_144_primary_doc.pdf +0 -0
- downloads_2025_onwards_2/1023731_2025-02-11_8X8_INC_DE_144/images/page_1.png +3 -0
- downloads_2025_onwards_2/1023731_2025-02-11_8X8_INC_DE_144/images/page_2.png +3 -0
- downloads_2025_onwards_2/1023731_2025-02-11_8X8_INC_DE_4/1023731_2025-02-11_8X8_INC_DE_4_wk-form4_1739313863.html +290 -0
- downloads_2025_onwards_2/1023731_2025-02-11_8X8_INC_DE_4/1023731_2025-02-11_8X8_INC_DE_4_wk-form4_1739313863.pdf +0 -0
- downloads_2025_onwards_2/1023731_2025-02-11_8X8_INC_DE_4/images/page_1.png +3 -0
- downloads_2025_onwards_2/1023731_2025-02-14_8X8_INC_DE_SCHEDULE_13G/1023731_2025-02-14_8X8_INC_DE_SCHEDULE_13G_primary_doc.html +413 -0
- downloads_2025_onwards_2/1023731_2025-02-14_8X8_INC_DE_SCHEDULE_13G/1023731_2025-02-14_8X8_INC_DE_SCHEDULE_13G_primary_doc.pdf +0 -0
- downloads_2025_onwards_2/1023731_2025-02-14_8X8_INC_DE_SCHEDULE_13G/images/page_1.png +3 -0
- downloads_2025_onwards_2/1023731_2025-02-14_8X8_INC_DE_SCHEDULE_13G/images/page_2.png +3 -0
- downloads_2025_onwards_2/1023731_2025-02-14_8X8_INC_DE_SCHEDULE_13G/images/page_3.png +3 -0
- downloads_2025_onwards_2/1023731_2025-02-18_8X8_INC_DE_4/1023731_2025-02-18_8X8_INC_DE_4_wk-form4_1739912930.html +290 -0
- downloads_2025_onwards_2/1023731_2025-02-18_8X8_INC_DE_4/1023731_2025-02-18_8X8_INC_DE_4_wk-form4_1739912930.pdf +0 -0
- downloads_2025_onwards_2/1023731_2025-02-18_8X8_INC_DE_4/images/page_1.png +3 -0
- downloads_2025_onwards_2/1023731_2025-02-20_8X8_INC_DE_4/1023731_2025-02-20_8X8_INC_DE_4_wk-form4_1740086507.html +287 -0
- downloads_2025_onwards_2/1023731_2025-02-20_8X8_INC_DE_4/1023731_2025-02-20_8X8_INC_DE_4_wk-form4_1740086507.pdf +0 -0
- downloads_2025_onwards_2/1023731_2025-02-20_8X8_INC_DE_4/images/page_1.png +3 -0
- downloads_2025_onwards_2/1023731_2025-03-17_8X8_INC_DE_144/1023731_2025-03-17_8X8_INC_DE_144_primary_doc.html +140 -0
- downloads_2025_onwards_2/1023731_2025-03-17_8X8_INC_DE_144/1023731_2025-03-17_8X8_INC_DE_144_primary_doc.pdf +0 -0
- downloads_2025_onwards_2/1023731_2025-03-17_8X8_INC_DE_144/images/page_1.png +3 -0
- downloads_2025_onwards_2/1023731_2025-03-17_8X8_INC_DE_144/images/page_2.png +3 -0
.gitattributes
CHANGED
@@ -82,3 +82,4 @@ downloads_2025_onwards/1004434_2025-02-28_AFFILIATED_MANAGERS_GROUP_INC_S-3ASR/d
|
|
82 |
downloads_2025_onwards/1005007_2025-01-10_Banc_of_America_Merrill_Lynch_Commercial_Mortgage_Inc_SF-3A/n4686_x3-sf3a1.pdf filter=lfs diff=lfs merge=lfs -text
|
83 |
downloads_2025_onwards/1006373_2025-03-03_DEUTSCHE_DWS_INVESTMENTS_VIT_FUNDS_N-CEN/primary_doc.pdf filter=lfs diff=lfs merge=lfs -text
|
84 |
downloads_2025_onwards/1006415_2025-01-13_HARTFORD_MUTUAL_FUNDS_INC_N-CEN/primary_doc.pdf filter=lfs diff=lfs merge=lfs -text
|
|
|
|
82 |
downloads_2025_onwards/1005007_2025-01-10_Banc_of_America_Merrill_Lynch_Commercial_Mortgage_Inc_SF-3A/n4686_x3-sf3a1.pdf filter=lfs diff=lfs merge=lfs -text
|
83 |
downloads_2025_onwards/1006373_2025-03-03_DEUTSCHE_DWS_INVESTMENTS_VIT_FUNDS_N-CEN/primary_doc.pdf filter=lfs diff=lfs merge=lfs -text
|
84 |
downloads_2025_onwards/1006415_2025-01-13_HARTFORD_MUTUAL_FUNDS_INC_N-CEN/primary_doc.pdf filter=lfs diff=lfs merge=lfs -text
|
85 |
+
downloads_2025_onwards_2/1748680_2025-03-31_1WS_Credit_Income_Fund_NPORT-P/1748680_2025-03-31_1WS_Credit_Income_Fund_NPORT-P_primary_doc.html filter=lfs diff=lfs merge=lfs -text
|
downloads_2025_onwards_2/1018368_2025-02-27_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_485BPOS/1018368_2025-02-27_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_485BPOS_abgrifi-20250227.htm
ADDED
@@ -0,0 +1,129 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
2 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
|
3 |
+
<html xmlns="http://www.w3.org/1999/xhtml" lang="en">
|
4 |
+
<head>
|
5 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
|
6 |
+
<meta http-equiv="Content-Security-Policy" content="upgrade-insecure-requests" />
|
7 |
+
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no" />
|
8 |
+
|
9 |
+
<link rel="shortcut icon" type="image/x-icon" href="/favicon.ico" />
|
10 |
+
<title>XBRL Viewer</title>
|
11 |
+
<script language="JavaScript">
|
12 |
+
/* <![CDATA[ */
|
13 |
+
/* Created by staff of the U.S. Securities and Exchange Commission.
|
14 |
+
* Data and content created by government employees within the scope of their employment
|
15 |
+
* are not subject to domestic copyright protection. 17 U.S.C. 105.
|
16 |
+
*
|
17 |
+
* This script checks the accession number of the document requested to determine
|
18 |
+
* the year and sequence of filing. If filed after the availability of ixviewer-plus
|
19 |
+
* this script redirects to that viewer, otherwise to a prior ixviewer in effect
|
20 |
+
* or deemed compatible with the filing.
|
21 |
+
*/
|
22 |
+
|
23 |
+
function loadViewer(ixvUrl) {
|
24 |
+
// load viewer in an iframe so the end user's browser URL is not changed
|
25 |
+
var iFrame = document.getElementById("ixvFrame");
|
26 |
+
iFrame.src = ixvUrl;
|
27 |
+
}
|
28 |
+
|
29 |
+
const url = location.href;
|
30 |
+
// url doc pattern is /Archives/edgar/data/ciknum/{10digits}{YY}{sequence}/{more params}
|
31 |
+
// uncomment one of the following urlPatterns depending on usage:
|
32 |
+
// for SEC.GOV: const urlPattern = /(\?doc=(\/Archives\/edgar\/data\/[0-9]+\/[0-9]{10}([0-9]{8})\/).*$)/;
|
33 |
+
// for Arelle GUI: const urlPattern = /(\?doc=(\/[0-9]+\/).*$)/;
|
34 |
+
const urlPattern = /(\?doc=(\/Archives\/edgar\/data\/[0-9]+\/[0-9]{10}([0-9]{8})\/).*$)/;
|
35 |
+
const ixvPlusNsPattern = /http:\/\/xbrl.sec.gov\/(ffd|sbs)\/.*$/;
|
36 |
+
var ixvUrl = null;
|
37 |
+
|
38 |
+
if (! urlPattern.test(url)) {
|
39 |
+
alert("Not an EDGAR inline XBRL document viewing request, please check URL");
|
40 |
+
// this hangs: loadViewer("/ixviewer/ix.html" + ixParams);
|
41 |
+
} else {
|
42 |
+
const match = url.match(urlPattern);
|
43 |
+
const ixParams = match[1];
|
44 |
+
const docPath = match[2];
|
45 |
+
const acsnYrSeq = match[3];
|
46 |
+
const acsnYr = Number(match[3].substring(0, 2));
|
47 |
+
let xhr = new XMLHttpRequest();
|
48 |
+
xhr.onreadystatechange = function() {
|
49 |
+
if (this.readyState == 4) {
|
50 |
+
if (this.status == 200) {
|
51 |
+
const ml = JSON.parse(this.responseText);
|
52 |
+
if (!(typeof ml === 'object' && "instance" in ml)) {
|
53 |
+
console.log("Metalinks does not have instance objects");
|
54 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
55 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
56 |
+
} else {
|
57 |
+
const numInstances = Object.keys(ml["instance"]).length;
|
58 |
+
let maxDocsPerInst = 0;
|
59 |
+
let hasIxvPlusExhibit = false;
|
60 |
+
Object.keys(ml["instance"]).forEach(instanceNames => {
|
61 |
+
let docsInInstance = instanceNames.split(" ").length;
|
62 |
+
if (docsInInstance > maxDocsPerInst)
|
63 |
+
maxDocsPerInst = docsInInstance;
|
64 |
+
if ("baseTaxonomies" in ml["instance"][instanceNames]) {
|
65 |
+
Object.keys(ml["instance"][instanceNames]["baseTaxonomies"]).forEach(baseTaxonomyUrl => {
|
66 |
+
if (ixvPlusNsPattern.test(baseTaxonomyUrl))
|
67 |
+
hasIxvPlusExhibit = true;
|
68 |
+
});
|
69 |
+
}
|
70 |
+
});
|
71 |
+
|
72 |
+
if (
|
73 |
+
(numInstances > 1 || maxDocsPerInst > 1 || hasIxvPlusExhibit || url.includes("&redline=true"))
|
74 |
+
|| acsnYr >= 25
|
75 |
+
)
|
76 |
+
loadViewer("/ixviewer-plus/ix.xhtml" + ixParams);
|
77 |
+
else
|
78 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
79 |
+
}
|
80 |
+
} else {
|
81 |
+
console.log("Unable to read MetaLinks.json for this accession");
|
82 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
83 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
84 |
+
}
|
85 |
+
}
|
86 |
+
};
|
87 |
+
xhr.ontimeout = function() {
|
88 |
+
console.log("Timeout reading MetaLinks.json for this accession");
|
89 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
90 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
91 |
+
};
|
92 |
+
xhr.open("GET", docPath + 'MetaLinks.json', true);
|
93 |
+
xhr.timeout = 2000; // milliseconds
|
94 |
+
xhr.send();
|
95 |
+
|
96 |
+
/* Arelle GUI usage: set title for tab in browser for when there are multiple tabs */
|
97 |
+
const urlTitleParamPattern = /&title=([^&]+),*$/;
|
98 |
+
if (urlTitleParamPattern.test(url)) {
|
99 |
+
const match = url.match(urlTitleParamPattern);
|
100 |
+
document.title = decodeURIComponent(match[1]);
|
101 |
+
}
|
102 |
+
|
103 |
+
/* alternative select viewer using accession number
|
104 |
+
|
105 |
+
const acsnYrSeq = match[3];
|
106 |
+
if (acsnYrSeq > "24905000") {
|
107 |
+
loadViewer(docPath + "ixbrlviewer.xhtml");
|
108 |
+
} else if (acsnYrSeq > "23905000") {
|
109 |
+
loadViewer("/ixviewer-plus/ix.xhtml" + ixParams);
|
110 |
+
} else {
|
111 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
112 |
+
}
|
113 |
+
|
114 |
+
*/
|
115 |
+
}
|
116 |
+
/* ]]> */
|
117 |
+
</script>
|
118 |
+
</head>
|
119 |
+
|
120 |
+
<body style="margin: 0">
|
121 |
+
<noscript>
|
122 |
+
Please enable JavaScript to use the EDGAR Inline XBRL Viewer.
|
123 |
+
</noscript>
|
124 |
+
<iframe id="ixvFrame"
|
125 |
+
title="Inline XBRL Viewer"
|
126 |
+
style="position: absolute; height: 100%; width: 100%; border: none"
|
127 |
+
/>
|
128 |
+
</body>
|
129 |
+
</html>
|
downloads_2025_onwards_2/1018368_2025-02-27_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_485BPOS/1018368_2025-02-27_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_485BPOS_abgrifi-20250227.pdf
ADDED
Binary file (1.21 kB). View file
|
|
downloads_2025_onwards_2/1018368_2025-02-27_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_485BPOS/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards_2/1018368_2025-03-04_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_497J/1018368_2025-03-04_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_497J_d11619892_497-j.htm
ADDED
@@ -0,0 +1,108 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<DOCUMENT>
|
2 |
+
<TYPE>497J
|
3 |
+
<SEQUENCE>1
|
4 |
+
<FILENAME>d11619892_497-j.htm
|
5 |
+
<TEXT>
|
6 |
+
<HTML>
|
7 |
+
<HEAD>
|
8 |
+
<TITLE></TITLE>
|
9 |
+
</HEAD>
|
10 |
+
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">
|
11 |
+
|
12 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">Seward & Kissel LLP</P>
|
13 |
+
|
14 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">901 K Street, NW</P>
|
15 |
+
|
16 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">Suite 800</P>
|
17 |
+
|
18 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">Washington, D.C. 20001</P>
|
19 |
+
|
20 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">(202) 737-8833 (phone)</P>
|
21 |
+
|
22 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">(202) 737-5184 (fax)</P>
|
23 |
+
|
24 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"> </P>
|
25 |
+
|
26 |
+
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
|
27 |
+
<TR STYLE="vertical-align: top">
|
28 |
+
<TD STYLE="font: 12pt Times New Roman, Times, Serif; width: 69%; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 0in"> </TD>
|
29 |
+
<TD STYLE="font: 12pt Times New Roman, Times, Serif; width: 31%; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 0in">March 4, 2025</TD></TR>
|
30 |
+
</TABLE>
|
31 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"> </P>
|
32 |
+
|
33 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"><U>VIA EDGAR</U></P>
|
34 |
+
|
35 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"> </P>
|
36 |
+
|
37 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in">Securities and Exchange Commission</P>
|
38 |
+
|
39 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in">100 F Street, NE</P>
|
40 |
+
|
41 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in">Washington, D.C. 20549</P>
|
42 |
+
|
43 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"> </P>
|
44 |
+
|
45 |
+
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
|
46 |
+
<TR STYLE="vertical-align: top">
|
47 |
+
<TD STYLE="width: 5%; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: -4.5pt">Re:</TD>
|
48 |
+
<TD STYLE="width: 53%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
|
49 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.8pt"><U>AB Cap Fund, Inc.</U></P>
|
50 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 12.7pt">-AB Small Cap Value Portfolio</P>
|
51 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 12.7pt">-AB All China Equity Portfolio</P>
|
52 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 12.7pt">-AB Mid Cap Value Portfolio</P>
|
53 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: -0.8pt">(File Nos. 002-29901 and 811-01716)</P>
|
54 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.8pt"><U>AB Core Opportunities Fund, Inc.</U></P>
|
55 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: -0.8pt">(File Nos. 333-90261 and 811-09687)</P>
|
56 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.8pt"><U>AB Equity Income Fund, Inc.</U></P>
|
57 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: -0.8pt">(File Nos. 033-66630 and 811-07916)</P>
|
58 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.8pt"><U>AB Global Real Estate Investment Fund, Inc.</U></P>
|
59 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: -0.8pt">(File Nos. 333-08153 and 811-07707)</P></TD>
|
60 |
+
<TD STYLE="width: 42%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
|
61 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.8pt"><U>AB Global Risk Allocation Fund, Inc.</U></P>
|
62 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: -0.8pt">(File Nos. 002-10988 and 811-00134)</P>
|
63 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.8pt"><U>AB Relative Value Fund, Inc.</U></P>
|
64 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: -0.8pt">(File Nos. 002-11023 and 811-00126)</P>
|
65 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.8pt"><U>AB Trust</U></P>
|
66 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 12.7pt">-AB Large Cap Value Fund (formerly, AB Value Fund)</P>
|
67 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 12.7pt">-AB Discovery Value Fund</P>
|
68 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 12.7pt">-AB International Value Fund</P>
|
69 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: -0.8pt">(File Nos. 333-51938 and 811-10221)</P></TD></TR>
|
70 |
+
</TABLE>
|
71 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"> </P>
|
72 |
+
|
73 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in">Ladies and Gentlemen:</P>
|
74 |
+
|
75 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"> </P>
|
76 |
+
|
77 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">On behalf of the above-referenced AB Funds (the
|
78 |
+
“Funds”), we are transmitting a certification pursuant to Rule 497(j) under the Securities Act of 1933. In this regard, we
|
79 |
+
certify that the Statement of Additional Information for the Funds that would have been filed under Rule 497(c) does not differ from that
|
80 |
+
included in the most recent post-effective amendment to each Fund’s registration statement. The post-effective amendment was filed
|
81 |
+
electronically with the Securities and Exchange Commission on February 27, 2025.</P>
|
82 |
+
|
83 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">A definitive form of the Prospectus for the
|
84 |
+
Funds was filed separately pursuant to Rule 497(c) on March 3, 2025.</P>
|
85 |
+
|
86 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">If you have any questions regarding the foregoing,
|
87 |
+
please call me at the above referenced number.</P>
|
88 |
+
|
89 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"> </P>
|
90 |
+
|
91 |
+
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
|
92 |
+
<TR STYLE="vertical-align: top">
|
93 |
+
<TD STYLE="font: 12pt Times New Roman, Times, Serif; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt"> </TD>
|
94 |
+
<TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
|
95 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Sincerely,</P>
|
96 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"> </P>
|
97 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"> </P>
|
98 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><U>/s/ Anna C. Weigand</U></P>
|
99 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt"> Anna C. Weigand</P></TD></TR>
|
100 |
+
</TABLE>
|
101 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"> </P>
|
102 |
+
|
103 |
+
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>
|
104 |
+
|
105 |
+
</BODY>
|
106 |
+
</HTML>
|
107 |
+
</TEXT>
|
108 |
+
</DOCUMENT>
|
downloads_2025_onwards_2/1018368_2025-03-04_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_497J/1018368_2025-03-04_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_497J_d11619892_497-j.pdf
ADDED
Binary file (15 kB). View file
|
|
downloads_2025_onwards_2/1018368_2025-03-04_AB_GLOBAL_REAL_ESTATE_INVESTMENT_FUND_INC_497J/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards_2/1018592_2025-01-27_AB_INSTITUTIONAL_FUNDS_INC_485BPOS/1018592_2025-01-27_AB_INSTITUTIONAL_FUNDS_INC_485BPOS_abgifi-20250127.htm
ADDED
@@ -0,0 +1,129 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
2 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
|
3 |
+
<html xmlns="http://www.w3.org/1999/xhtml" lang="en">
|
4 |
+
<head>
|
5 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
|
6 |
+
<meta http-equiv="Content-Security-Policy" content="upgrade-insecure-requests" />
|
7 |
+
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no" />
|
8 |
+
|
9 |
+
<link rel="shortcut icon" type="image/x-icon" href="/favicon.ico" />
|
10 |
+
<title>XBRL Viewer</title>
|
11 |
+
<script language="JavaScript">
|
12 |
+
/* <![CDATA[ */
|
13 |
+
/* Created by staff of the U.S. Securities and Exchange Commission.
|
14 |
+
* Data and content created by government employees within the scope of their employment
|
15 |
+
* are not subject to domestic copyright protection. 17 U.S.C. 105.
|
16 |
+
*
|
17 |
+
* This script checks the accession number of the document requested to determine
|
18 |
+
* the year and sequence of filing. If filed after the availability of ixviewer-plus
|
19 |
+
* this script redirects to that viewer, otherwise to a prior ixviewer in effect
|
20 |
+
* or deemed compatible with the filing.
|
21 |
+
*/
|
22 |
+
|
23 |
+
function loadViewer(ixvUrl) {
|
24 |
+
// load viewer in an iframe so the end user's browser URL is not changed
|
25 |
+
var iFrame = document.getElementById("ixvFrame");
|
26 |
+
iFrame.src = ixvUrl;
|
27 |
+
}
|
28 |
+
|
29 |
+
const url = location.href;
|
30 |
+
// url doc pattern is /Archives/edgar/data/ciknum/{10digits}{YY}{sequence}/{more params}
|
31 |
+
// uncomment one of the following urlPatterns depending on usage:
|
32 |
+
// for SEC.GOV: const urlPattern = /(\?doc=(\/Archives\/edgar\/data\/[0-9]+\/[0-9]{10}([0-9]{8})\/).*$)/;
|
33 |
+
// for Arelle GUI: const urlPattern = /(\?doc=(\/[0-9]+\/).*$)/;
|
34 |
+
const urlPattern = /(\?doc=(\/Archives\/edgar\/data\/[0-9]+\/[0-9]{10}([0-9]{8})\/).*$)/;
|
35 |
+
const ixvPlusNsPattern = /http:\/\/xbrl.sec.gov\/(ffd|sbs)\/.*$/;
|
36 |
+
var ixvUrl = null;
|
37 |
+
|
38 |
+
if (! urlPattern.test(url)) {
|
39 |
+
alert("Not an EDGAR inline XBRL document viewing request, please check URL");
|
40 |
+
// this hangs: loadViewer("/ixviewer/ix.html" + ixParams);
|
41 |
+
} else {
|
42 |
+
const match = url.match(urlPattern);
|
43 |
+
const ixParams = match[1];
|
44 |
+
const docPath = match[2];
|
45 |
+
const acsnYrSeq = match[3];
|
46 |
+
const acsnYr = Number(match[3].substring(0, 2));
|
47 |
+
let xhr = new XMLHttpRequest();
|
48 |
+
xhr.onreadystatechange = function() {
|
49 |
+
if (this.readyState == 4) {
|
50 |
+
if (this.status == 200) {
|
51 |
+
const ml = JSON.parse(this.responseText);
|
52 |
+
if (!(typeof ml === 'object' && "instance" in ml)) {
|
53 |
+
console.log("Metalinks does not have instance objects");
|
54 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
55 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
56 |
+
} else {
|
57 |
+
const numInstances = Object.keys(ml["instance"]).length;
|
58 |
+
let maxDocsPerInst = 0;
|
59 |
+
let hasIxvPlusExhibit = false;
|
60 |
+
Object.keys(ml["instance"]).forEach(instanceNames => {
|
61 |
+
let docsInInstance = instanceNames.split(" ").length;
|
62 |
+
if (docsInInstance > maxDocsPerInst)
|
63 |
+
maxDocsPerInst = docsInInstance;
|
64 |
+
if ("baseTaxonomies" in ml["instance"][instanceNames]) {
|
65 |
+
Object.keys(ml["instance"][instanceNames]["baseTaxonomies"]).forEach(baseTaxonomyUrl => {
|
66 |
+
if (ixvPlusNsPattern.test(baseTaxonomyUrl))
|
67 |
+
hasIxvPlusExhibit = true;
|
68 |
+
});
|
69 |
+
}
|
70 |
+
});
|
71 |
+
|
72 |
+
if (
|
73 |
+
(numInstances > 1 || maxDocsPerInst > 1 || hasIxvPlusExhibit || url.includes("&redline=true"))
|
74 |
+
|| acsnYr >= 25
|
75 |
+
)
|
76 |
+
loadViewer("/ixviewer-plus/ix.xhtml" + ixParams);
|
77 |
+
else
|
78 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
79 |
+
}
|
80 |
+
} else {
|
81 |
+
console.log("Unable to read MetaLinks.json for this accession");
|
82 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
83 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
84 |
+
}
|
85 |
+
}
|
86 |
+
};
|
87 |
+
xhr.ontimeout = function() {
|
88 |
+
console.log("Timeout reading MetaLinks.json for this accession");
|
89 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
90 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
91 |
+
};
|
92 |
+
xhr.open("GET", docPath + 'MetaLinks.json', true);
|
93 |
+
xhr.timeout = 2000; // milliseconds
|
94 |
+
xhr.send();
|
95 |
+
|
96 |
+
/* Arelle GUI usage: set title for tab in browser for when there are multiple tabs */
|
97 |
+
const urlTitleParamPattern = /&title=([^&]+),*$/;
|
98 |
+
if (urlTitleParamPattern.test(url)) {
|
99 |
+
const match = url.match(urlTitleParamPattern);
|
100 |
+
document.title = decodeURIComponent(match[1]);
|
101 |
+
}
|
102 |
+
|
103 |
+
/* alternative select viewer using accession number
|
104 |
+
|
105 |
+
const acsnYrSeq = match[3];
|
106 |
+
if (acsnYrSeq > "24905000") {
|
107 |
+
loadViewer(docPath + "ixbrlviewer.xhtml");
|
108 |
+
} else if (acsnYrSeq > "23905000") {
|
109 |
+
loadViewer("/ixviewer-plus/ix.xhtml" + ixParams);
|
110 |
+
} else {
|
111 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
112 |
+
}
|
113 |
+
|
114 |
+
*/
|
115 |
+
}
|
116 |
+
/* ]]> */
|
117 |
+
</script>
|
118 |
+
</head>
|
119 |
+
|
120 |
+
<body style="margin: 0">
|
121 |
+
<noscript>
|
122 |
+
Please enable JavaScript to use the EDGAR Inline XBRL Viewer.
|
123 |
+
</noscript>
|
124 |
+
<iframe id="ixvFrame"
|
125 |
+
title="Inline XBRL Viewer"
|
126 |
+
style="position: absolute; height: 100%; width: 100%; border: none"
|
127 |
+
/>
|
128 |
+
</body>
|
129 |
+
</html>
|
downloads_2025_onwards_2/1018592_2025-01-27_AB_INSTITUTIONAL_FUNDS_INC_485BPOS/1018592_2025-01-27_AB_INSTITUTIONAL_FUNDS_INC_485BPOS_abgifi-20250127.pdf
ADDED
Binary file (1.21 kB). View file
|
|
downloads_2025_onwards_2/1018592_2025-01-27_AB_INSTITUTIONAL_FUNDS_INC_485BPOS/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards_2/1018840_2025-01-13_ABERCROMBIE__FITCH_CO_DE_8-K/1018840_2025-01-13_ABERCROMBIE__FITCH_CO_DE_8-K_anf-20250113.htm
ADDED
@@ -0,0 +1,129 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
2 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
|
3 |
+
<html xmlns="http://www.w3.org/1999/xhtml" lang="en">
|
4 |
+
<head>
|
5 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
|
6 |
+
<meta http-equiv="Content-Security-Policy" content="upgrade-insecure-requests" />
|
7 |
+
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no" />
|
8 |
+
|
9 |
+
<link rel="shortcut icon" type="image/x-icon" href="/favicon.ico" />
|
10 |
+
<title>XBRL Viewer</title>
|
11 |
+
<script language="JavaScript">
|
12 |
+
/* <![CDATA[ */
|
13 |
+
/* Created by staff of the U.S. Securities and Exchange Commission.
|
14 |
+
* Data and content created by government employees within the scope of their employment
|
15 |
+
* are not subject to domestic copyright protection. 17 U.S.C. 105.
|
16 |
+
*
|
17 |
+
* This script checks the accession number of the document requested to determine
|
18 |
+
* the year and sequence of filing. If filed after the availability of ixviewer-plus
|
19 |
+
* this script redirects to that viewer, otherwise to a prior ixviewer in effect
|
20 |
+
* or deemed compatible with the filing.
|
21 |
+
*/
|
22 |
+
|
23 |
+
function loadViewer(ixvUrl) {
|
24 |
+
// load viewer in an iframe so the end user's browser URL is not changed
|
25 |
+
var iFrame = document.getElementById("ixvFrame");
|
26 |
+
iFrame.src = ixvUrl;
|
27 |
+
}
|
28 |
+
|
29 |
+
const url = location.href;
|
30 |
+
// url doc pattern is /Archives/edgar/data/ciknum/{10digits}{YY}{sequence}/{more params}
|
31 |
+
// uncomment one of the following urlPatterns depending on usage:
|
32 |
+
// for SEC.GOV: const urlPattern = /(\?doc=(\/Archives\/edgar\/data\/[0-9]+\/[0-9]{10}([0-9]{8})\/).*$)/;
|
33 |
+
// for Arelle GUI: const urlPattern = /(\?doc=(\/[0-9]+\/).*$)/;
|
34 |
+
const urlPattern = /(\?doc=(\/Archives\/edgar\/data\/[0-9]+\/[0-9]{10}([0-9]{8})\/).*$)/;
|
35 |
+
const ixvPlusNsPattern = /http:\/\/xbrl.sec.gov\/(ffd|sbs)\/.*$/;
|
36 |
+
var ixvUrl = null;
|
37 |
+
|
38 |
+
if (! urlPattern.test(url)) {
|
39 |
+
alert("Not an EDGAR inline XBRL document viewing request, please check URL");
|
40 |
+
// this hangs: loadViewer("/ixviewer/ix.html" + ixParams);
|
41 |
+
} else {
|
42 |
+
const match = url.match(urlPattern);
|
43 |
+
const ixParams = match[1];
|
44 |
+
const docPath = match[2];
|
45 |
+
const acsnYrSeq = match[3];
|
46 |
+
const acsnYr = Number(match[3].substring(0, 2));
|
47 |
+
let xhr = new XMLHttpRequest();
|
48 |
+
xhr.onreadystatechange = function() {
|
49 |
+
if (this.readyState == 4) {
|
50 |
+
if (this.status == 200) {
|
51 |
+
const ml = JSON.parse(this.responseText);
|
52 |
+
if (!(typeof ml === 'object' && "instance" in ml)) {
|
53 |
+
console.log("Metalinks does not have instance objects");
|
54 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
55 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
56 |
+
} else {
|
57 |
+
const numInstances = Object.keys(ml["instance"]).length;
|
58 |
+
let maxDocsPerInst = 0;
|
59 |
+
let hasIxvPlusExhibit = false;
|
60 |
+
Object.keys(ml["instance"]).forEach(instanceNames => {
|
61 |
+
let docsInInstance = instanceNames.split(" ").length;
|
62 |
+
if (docsInInstance > maxDocsPerInst)
|
63 |
+
maxDocsPerInst = docsInInstance;
|
64 |
+
if ("baseTaxonomies" in ml["instance"][instanceNames]) {
|
65 |
+
Object.keys(ml["instance"][instanceNames]["baseTaxonomies"]).forEach(baseTaxonomyUrl => {
|
66 |
+
if (ixvPlusNsPattern.test(baseTaxonomyUrl))
|
67 |
+
hasIxvPlusExhibit = true;
|
68 |
+
});
|
69 |
+
}
|
70 |
+
});
|
71 |
+
|
72 |
+
if (
|
73 |
+
(numInstances > 1 || maxDocsPerInst > 1 || hasIxvPlusExhibit || url.includes("&redline=true"))
|
74 |
+
|| acsnYr >= 25
|
75 |
+
)
|
76 |
+
loadViewer("/ixviewer-plus/ix.xhtml" + ixParams);
|
77 |
+
else
|
78 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
79 |
+
}
|
80 |
+
} else {
|
81 |
+
console.log("Unable to read MetaLinks.json for this accession");
|
82 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
83 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
84 |
+
}
|
85 |
+
}
|
86 |
+
};
|
87 |
+
xhr.ontimeout = function() {
|
88 |
+
console.log("Timeout reading MetaLinks.json for this accession");
|
89 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
90 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
91 |
+
};
|
92 |
+
xhr.open("GET", docPath + 'MetaLinks.json', true);
|
93 |
+
xhr.timeout = 2000; // milliseconds
|
94 |
+
xhr.send();
|
95 |
+
|
96 |
+
/* Arelle GUI usage: set title for tab in browser for when there are multiple tabs */
|
97 |
+
const urlTitleParamPattern = /&title=([^&]+),*$/;
|
98 |
+
if (urlTitleParamPattern.test(url)) {
|
99 |
+
const match = url.match(urlTitleParamPattern);
|
100 |
+
document.title = decodeURIComponent(match[1]);
|
101 |
+
}
|
102 |
+
|
103 |
+
/* alternative select viewer using accession number
|
104 |
+
|
105 |
+
const acsnYrSeq = match[3];
|
106 |
+
if (acsnYrSeq > "24905000") {
|
107 |
+
loadViewer(docPath + "ixbrlviewer.xhtml");
|
108 |
+
} else if (acsnYrSeq > "23905000") {
|
109 |
+
loadViewer("/ixviewer-plus/ix.xhtml" + ixParams);
|
110 |
+
} else {
|
111 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
112 |
+
}
|
113 |
+
|
114 |
+
*/
|
115 |
+
}
|
116 |
+
/* ]]> */
|
117 |
+
</script>
|
118 |
+
</head>
|
119 |
+
|
120 |
+
<body style="margin: 0">
|
121 |
+
<noscript>
|
122 |
+
Please enable JavaScript to use the EDGAR Inline XBRL Viewer.
|
123 |
+
</noscript>
|
124 |
+
<iframe id="ixvFrame"
|
125 |
+
title="Inline XBRL Viewer"
|
126 |
+
style="position: absolute; height: 100%; width: 100%; border: none"
|
127 |
+
/>
|
128 |
+
</body>
|
129 |
+
</html>
|
downloads_2025_onwards_2/1018840_2025-01-13_ABERCROMBIE__FITCH_CO_DE_8-K/1018840_2025-01-13_ABERCROMBIE__FITCH_CO_DE_8-K_anf-20250113.pdf
ADDED
Binary file (1.21 kB). View file
|
|
downloads_2025_onwards_2/1018840_2025-01-13_ABERCROMBIE__FITCH_CO_DE_8-K/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards_2/1018840_2025-03-06_ABERCROMBIE__FITCH_CO_DE_8-K/1018840_2025-03-06_ABERCROMBIE__FITCH_CO_DE_8-K_anf-20250305.htm
ADDED
@@ -0,0 +1,129 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
2 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
|
3 |
+
<html xmlns="http://www.w3.org/1999/xhtml" lang="en">
|
4 |
+
<head>
|
5 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
|
6 |
+
<meta http-equiv="Content-Security-Policy" content="upgrade-insecure-requests" />
|
7 |
+
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no" />
|
8 |
+
|
9 |
+
<link rel="shortcut icon" type="image/x-icon" href="/favicon.ico" />
|
10 |
+
<title>XBRL Viewer</title>
|
11 |
+
<script language="JavaScript">
|
12 |
+
/* <![CDATA[ */
|
13 |
+
/* Created by staff of the U.S. Securities and Exchange Commission.
|
14 |
+
* Data and content created by government employees within the scope of their employment
|
15 |
+
* are not subject to domestic copyright protection. 17 U.S.C. 105.
|
16 |
+
*
|
17 |
+
* This script checks the accession number of the document requested to determine
|
18 |
+
* the year and sequence of filing. If filed after the availability of ixviewer-plus
|
19 |
+
* this script redirects to that viewer, otherwise to a prior ixviewer in effect
|
20 |
+
* or deemed compatible with the filing.
|
21 |
+
*/
|
22 |
+
|
23 |
+
function loadViewer(ixvUrl) {
|
24 |
+
// load viewer in an iframe so the end user's browser URL is not changed
|
25 |
+
var iFrame = document.getElementById("ixvFrame");
|
26 |
+
iFrame.src = ixvUrl;
|
27 |
+
}
|
28 |
+
|
29 |
+
const url = location.href;
|
30 |
+
// url doc pattern is /Archives/edgar/data/ciknum/{10digits}{YY}{sequence}/{more params}
|
31 |
+
// uncomment one of the following urlPatterns depending on usage:
|
32 |
+
// for SEC.GOV: const urlPattern = /(\?doc=(\/Archives\/edgar\/data\/[0-9]+\/[0-9]{10}([0-9]{8})\/).*$)/;
|
33 |
+
// for Arelle GUI: const urlPattern = /(\?doc=(\/[0-9]+\/).*$)/;
|
34 |
+
const urlPattern = /(\?doc=(\/Archives\/edgar\/data\/[0-9]+\/[0-9]{10}([0-9]{8})\/).*$)/;
|
35 |
+
const ixvPlusNsPattern = /http:\/\/xbrl.sec.gov\/(ffd|sbs)\/.*$/;
|
36 |
+
var ixvUrl = null;
|
37 |
+
|
38 |
+
if (! urlPattern.test(url)) {
|
39 |
+
alert("Not an EDGAR inline XBRL document viewing request, please check URL");
|
40 |
+
// this hangs: loadViewer("/ixviewer/ix.html" + ixParams);
|
41 |
+
} else {
|
42 |
+
const match = url.match(urlPattern);
|
43 |
+
const ixParams = match[1];
|
44 |
+
const docPath = match[2];
|
45 |
+
const acsnYrSeq = match[3];
|
46 |
+
const acsnYr = Number(match[3].substring(0, 2));
|
47 |
+
let xhr = new XMLHttpRequest();
|
48 |
+
xhr.onreadystatechange = function() {
|
49 |
+
if (this.readyState == 4) {
|
50 |
+
if (this.status == 200) {
|
51 |
+
const ml = JSON.parse(this.responseText);
|
52 |
+
if (!(typeof ml === 'object' && "instance" in ml)) {
|
53 |
+
console.log("Metalinks does not have instance objects");
|
54 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
55 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
56 |
+
} else {
|
57 |
+
const numInstances = Object.keys(ml["instance"]).length;
|
58 |
+
let maxDocsPerInst = 0;
|
59 |
+
let hasIxvPlusExhibit = false;
|
60 |
+
Object.keys(ml["instance"]).forEach(instanceNames => {
|
61 |
+
let docsInInstance = instanceNames.split(" ").length;
|
62 |
+
if (docsInInstance > maxDocsPerInst)
|
63 |
+
maxDocsPerInst = docsInInstance;
|
64 |
+
if ("baseTaxonomies" in ml["instance"][instanceNames]) {
|
65 |
+
Object.keys(ml["instance"][instanceNames]["baseTaxonomies"]).forEach(baseTaxonomyUrl => {
|
66 |
+
if (ixvPlusNsPattern.test(baseTaxonomyUrl))
|
67 |
+
hasIxvPlusExhibit = true;
|
68 |
+
});
|
69 |
+
}
|
70 |
+
});
|
71 |
+
|
72 |
+
if (
|
73 |
+
(numInstances > 1 || maxDocsPerInst > 1 || hasIxvPlusExhibit || url.includes("&redline=true"))
|
74 |
+
|| acsnYr >= 25
|
75 |
+
)
|
76 |
+
loadViewer("/ixviewer-plus/ix.xhtml" + ixParams);
|
77 |
+
else
|
78 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
79 |
+
}
|
80 |
+
} else {
|
81 |
+
console.log("Unable to read MetaLinks.json for this accession");
|
82 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
83 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
84 |
+
}
|
85 |
+
}
|
86 |
+
};
|
87 |
+
xhr.ontimeout = function() {
|
88 |
+
console.log("Timeout reading MetaLinks.json for this accession");
|
89 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
90 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
91 |
+
};
|
92 |
+
xhr.open("GET", docPath + 'MetaLinks.json', true);
|
93 |
+
xhr.timeout = 2000; // milliseconds
|
94 |
+
xhr.send();
|
95 |
+
|
96 |
+
/* Arelle GUI usage: set title for tab in browser for when there are multiple tabs */
|
97 |
+
const urlTitleParamPattern = /&title=([^&]+),*$/;
|
98 |
+
if (urlTitleParamPattern.test(url)) {
|
99 |
+
const match = url.match(urlTitleParamPattern);
|
100 |
+
document.title = decodeURIComponent(match[1]);
|
101 |
+
}
|
102 |
+
|
103 |
+
/* alternative select viewer using accession number
|
104 |
+
|
105 |
+
const acsnYrSeq = match[3];
|
106 |
+
if (acsnYrSeq > "24905000") {
|
107 |
+
loadViewer(docPath + "ixbrlviewer.xhtml");
|
108 |
+
} else if (acsnYrSeq > "23905000") {
|
109 |
+
loadViewer("/ixviewer-plus/ix.xhtml" + ixParams);
|
110 |
+
} else {
|
111 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
112 |
+
}
|
113 |
+
|
114 |
+
*/
|
115 |
+
}
|
116 |
+
/* ]]> */
|
117 |
+
</script>
|
118 |
+
</head>
|
119 |
+
|
120 |
+
<body style="margin: 0">
|
121 |
+
<noscript>
|
122 |
+
Please enable JavaScript to use the EDGAR Inline XBRL Viewer.
|
123 |
+
</noscript>
|
124 |
+
<iframe id="ixvFrame"
|
125 |
+
title="Inline XBRL Viewer"
|
126 |
+
style="position: absolute; height: 100%; width: 100%; border: none"
|
127 |
+
/>
|
128 |
+
</body>
|
129 |
+
</html>
|
downloads_2025_onwards_2/1018840_2025-03-06_ABERCROMBIE__FITCH_CO_DE_8-K/1018840_2025-03-06_ABERCROMBIE__FITCH_CO_DE_8-K_anf-20250305.pdf
ADDED
Binary file (1.21 kB). View file
|
|
downloads_2025_onwards_2/1018840_2025-03-06_ABERCROMBIE__FITCH_CO_DE_8-K/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards_2/1018840_2025-03-31_ABERCROMBIE__FITCH_CO_DE_10-K/1018840_2025-03-31_ABERCROMBIE__FITCH_CO_DE_10-K_anf-20250201.htm
ADDED
@@ -0,0 +1,129 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
2 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
|
3 |
+
<html xmlns="http://www.w3.org/1999/xhtml" lang="en">
|
4 |
+
<head>
|
5 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
|
6 |
+
<meta http-equiv="Content-Security-Policy" content="upgrade-insecure-requests" />
|
7 |
+
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no" />
|
8 |
+
|
9 |
+
<link rel="shortcut icon" type="image/x-icon" href="/favicon.ico" />
|
10 |
+
<title>XBRL Viewer</title>
|
11 |
+
<script language="JavaScript">
|
12 |
+
/* <![CDATA[ */
|
13 |
+
/* Created by staff of the U.S. Securities and Exchange Commission.
|
14 |
+
* Data and content created by government employees within the scope of their employment
|
15 |
+
* are not subject to domestic copyright protection. 17 U.S.C. 105.
|
16 |
+
*
|
17 |
+
* This script checks the accession number of the document requested to determine
|
18 |
+
* the year and sequence of filing. If filed after the availability of ixviewer-plus
|
19 |
+
* this script redirects to that viewer, otherwise to a prior ixviewer in effect
|
20 |
+
* or deemed compatible with the filing.
|
21 |
+
*/
|
22 |
+
|
23 |
+
function loadViewer(ixvUrl) {
|
24 |
+
// load viewer in an iframe so the end user's browser URL is not changed
|
25 |
+
var iFrame = document.getElementById("ixvFrame");
|
26 |
+
iFrame.src = ixvUrl;
|
27 |
+
}
|
28 |
+
|
29 |
+
const url = location.href;
|
30 |
+
// url doc pattern is /Archives/edgar/data/ciknum/{10digits}{YY}{sequence}/{more params}
|
31 |
+
// uncomment one of the following urlPatterns depending on usage:
|
32 |
+
// for SEC.GOV: const urlPattern = /(\?doc=(\/Archives\/edgar\/data\/[0-9]+\/[0-9]{10}([0-9]{8})\/).*$)/;
|
33 |
+
// for Arelle GUI: const urlPattern = /(\?doc=(\/[0-9]+\/).*$)/;
|
34 |
+
const urlPattern = /(\?doc=(\/Archives\/edgar\/data\/[0-9]+\/[0-9]{10}([0-9]{8})\/).*$)/;
|
35 |
+
const ixvPlusNsPattern = /http:\/\/xbrl.sec.gov\/(ffd|sbs)\/.*$/;
|
36 |
+
var ixvUrl = null;
|
37 |
+
|
38 |
+
if (! urlPattern.test(url)) {
|
39 |
+
alert("Not an EDGAR inline XBRL document viewing request, please check URL");
|
40 |
+
// this hangs: loadViewer("/ixviewer/ix.html" + ixParams);
|
41 |
+
} else {
|
42 |
+
const match = url.match(urlPattern);
|
43 |
+
const ixParams = match[1];
|
44 |
+
const docPath = match[2];
|
45 |
+
const acsnYrSeq = match[3];
|
46 |
+
const acsnYr = Number(match[3].substring(0, 2));
|
47 |
+
let xhr = new XMLHttpRequest();
|
48 |
+
xhr.onreadystatechange = function() {
|
49 |
+
if (this.readyState == 4) {
|
50 |
+
if (this.status == 200) {
|
51 |
+
const ml = JSON.parse(this.responseText);
|
52 |
+
if (!(typeof ml === 'object' && "instance" in ml)) {
|
53 |
+
console.log("Metalinks does not have instance objects");
|
54 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
55 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
56 |
+
} else {
|
57 |
+
const numInstances = Object.keys(ml["instance"]).length;
|
58 |
+
let maxDocsPerInst = 0;
|
59 |
+
let hasIxvPlusExhibit = false;
|
60 |
+
Object.keys(ml["instance"]).forEach(instanceNames => {
|
61 |
+
let docsInInstance = instanceNames.split(" ").length;
|
62 |
+
if (docsInInstance > maxDocsPerInst)
|
63 |
+
maxDocsPerInst = docsInInstance;
|
64 |
+
if ("baseTaxonomies" in ml["instance"][instanceNames]) {
|
65 |
+
Object.keys(ml["instance"][instanceNames]["baseTaxonomies"]).forEach(baseTaxonomyUrl => {
|
66 |
+
if (ixvPlusNsPattern.test(baseTaxonomyUrl))
|
67 |
+
hasIxvPlusExhibit = true;
|
68 |
+
});
|
69 |
+
}
|
70 |
+
});
|
71 |
+
|
72 |
+
if (
|
73 |
+
(numInstances > 1 || maxDocsPerInst > 1 || hasIxvPlusExhibit || url.includes("&redline=true"))
|
74 |
+
|| acsnYr >= 25
|
75 |
+
)
|
76 |
+
loadViewer("/ixviewer-plus/ix.xhtml" + ixParams);
|
77 |
+
else
|
78 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
79 |
+
}
|
80 |
+
} else {
|
81 |
+
console.log("Unable to read MetaLinks.json for this accession");
|
82 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
83 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
84 |
+
}
|
85 |
+
}
|
86 |
+
};
|
87 |
+
xhr.ontimeout = function() {
|
88 |
+
console.log("Timeout reading MetaLinks.json for this accession");
|
89 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
90 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
91 |
+
};
|
92 |
+
xhr.open("GET", docPath + 'MetaLinks.json', true);
|
93 |
+
xhr.timeout = 2000; // milliseconds
|
94 |
+
xhr.send();
|
95 |
+
|
96 |
+
/* Arelle GUI usage: set title for tab in browser for when there are multiple tabs */
|
97 |
+
const urlTitleParamPattern = /&title=([^&]+),*$/;
|
98 |
+
if (urlTitleParamPattern.test(url)) {
|
99 |
+
const match = url.match(urlTitleParamPattern);
|
100 |
+
document.title = decodeURIComponent(match[1]);
|
101 |
+
}
|
102 |
+
|
103 |
+
/* alternative select viewer using accession number
|
104 |
+
|
105 |
+
const acsnYrSeq = match[3];
|
106 |
+
if (acsnYrSeq > "24905000") {
|
107 |
+
loadViewer(docPath + "ixbrlviewer.xhtml");
|
108 |
+
} else if (acsnYrSeq > "23905000") {
|
109 |
+
loadViewer("/ixviewer-plus/ix.xhtml" + ixParams);
|
110 |
+
} else {
|
111 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
112 |
+
}
|
113 |
+
|
114 |
+
*/
|
115 |
+
}
|
116 |
+
/* ]]> */
|
117 |
+
</script>
|
118 |
+
</head>
|
119 |
+
|
120 |
+
<body style="margin: 0">
|
121 |
+
<noscript>
|
122 |
+
Please enable JavaScript to use the EDGAR Inline XBRL Viewer.
|
123 |
+
</noscript>
|
124 |
+
<iframe id="ixvFrame"
|
125 |
+
title="Inline XBRL Viewer"
|
126 |
+
style="position: absolute; height: 100%; width: 100%; border: none"
|
127 |
+
/>
|
128 |
+
</body>
|
129 |
+
</html>
|
downloads_2025_onwards_2/1018840_2025-03-31_ABERCROMBIE__FITCH_CO_DE_10-K/1018840_2025-03-31_ABERCROMBIE__FITCH_CO_DE_10-K_anf-20250201.pdf
ADDED
Binary file (1.21 kB). View file
|
|
downloads_2025_onwards_2/1018840_2025-03-31_ABERCROMBIE__FITCH_CO_DE_10-K/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards_2/1023731_2025-01-16_8X8_INC_DE_4/1023731_2025-01-16_8X8_INC_DE_4_wk-form4_1737062003.html
ADDED
@@ -0,0 +1,287 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
|
2 |
+
<html>
|
3 |
+
<head>
|
4 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
|
5 |
+
<title>SEC FORM
|
6 |
+
4</title>
|
7 |
+
<style type="text/css">
|
8 |
+
.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
|
9 |
+
.FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
|
10 |
+
.FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
|
11 |
+
.SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
|
12 |
+
.FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
|
13 |
+
.FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
|
14 |
+
.FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
|
15 |
+
.FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
|
16 |
+
.FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
|
17 |
+
.FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
|
18 |
+
.FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
19 |
+
.FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
20 |
+
.SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
21 |
+
.SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
|
22 |
+
.SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
|
23 |
+
.MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
24 |
+
.FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
25 |
+
.FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
|
26 |
+
.FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
27 |
+
.FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
|
28 |
+
.SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif;
|
29 |
+
font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
|
30 |
+
.FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
31 |
+
.CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid; border-color: black:}
|
32 |
+
body {background: white;}
|
33 |
+
</style>
|
34 |
+
</head>
|
35 |
+
<body>SEC Form 4
|
36 |
+
<table width="100%" border="0" cellspacing="0" cellpadding="4">
|
37 |
+
<tr>
|
38 |
+
<td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 4</td>
|
39 |
+
<td rowspan="2" width="60%" valign="middle" align="center">
|
40 |
+
<span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span>
|
41 |
+
</td>
|
42 |
+
<td rowspan="2" width="20%" valign="top" align="center"><table width="100%" border="1" summary="OMB Approval Status Box">
|
43 |
+
<tr><td class="FormTextC">OMB APPROVAL</td></tr>
|
44 |
+
<tr><td><table width="100%" border="0" summary="OMB Interior Box">
|
45 |
+
<tr>
|
46 |
+
<td class="SmallFormText" colspan="3">OMB Number:</td>
|
47 |
+
<td class="SmallFormTextR">3235-0287</td>
|
48 |
+
</tr>
|
49 |
+
<tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr>
|
50 |
+
<tr>
|
51 |
+
<td class="SmallFormText" colspan="3">hours per response:</td>
|
52 |
+
<td class="SmallFormTextR">0.5</td>
|
53 |
+
</tr>
|
54 |
+
</table></td></tr>
|
55 |
+
</table></td>
|
56 |
+
</tr>
|
57 |
+
<tr valign="middle">
|
58 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td> </td></tr></table></td>
|
59 |
+
<td class="SmallFormText">Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
|
60 |
+
<i>See</i>
|
61 |
+
|
62 |
+
Instruction 1(b).</td>
|
63 |
+
</tr>
|
64 |
+
<tr valign="middle">
|
65 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td><span class="FormData">X</span></td></tr></table></td>
|
66 |
+
<td class="SmallFormText">Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. </td>
|
67 |
+
</tr>
|
68 |
+
</table>
|
69 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
70 |
+
<tr>
|
71 |
+
<td rowspan="4" width="35%" valign="top">
|
72 |
+
<span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001956914">Kraus Kevin</a></td></tr></table>
|
73 |
+
<hr width="98%">
|
74 |
+
<table border="0" width="100%"><tr>
|
75 |
+
<td width="33%" class="MedSmallFormText">(Last)</td>
|
76 |
+
<td width="33%" class="MedSmallFormText">(First)</td>
|
77 |
+
<td width="33%" class="MedSmallFormText">(Middle)</td>
|
78 |
+
</tr></table>
|
79 |
+
<table border="0" width="100%">
|
80 |
+
<tr><td><span class="FormData">C/O 8X8 INC 675 CREEKSIDE WAY</span></td></tr>
|
81 |
+
<tr><td><span class="FormData"></span></td></tr>
|
82 |
+
</table>
|
83 |
+
<hr width="98%">
|
84 |
+
<span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr>
|
85 |
+
<td width="33%"><span class="FormData">CAMPBELL</span></td>
|
86 |
+
<td width="33%"><span class="FormData">CA</span></td>
|
87 |
+
<td width="33%"><span class="FormData">95008</span></td>
|
88 |
+
</tr></table>
|
89 |
+
<hr width="98%">
|
90 |
+
<table border="0" width="100%"><tr>
|
91 |
+
<td width="33%" class="MedSmallFormText">(City)</td>
|
92 |
+
<td width="33%" class="MedSmallFormText">(State)</td>
|
93 |
+
<td width="33%" class="MedSmallFormText">(Zip)</td>
|
94 |
+
</tr></table>
|
95 |
+
</td>
|
96 |
+
<td width="35%" valign="top">
|
97 |
+
<span class="MedSmallFormText">2. Issuer Name <b>and</b> Ticker or Trading Symbol
|
98 |
+
</span><br><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001023731">8X8 INC /DE/</a>
|
99 |
+
[ <span class="FormData">EGHT</span> ]
|
100 |
+
</td>
|
101 |
+
<td rowspan="2" valign="top">
|
102 |
+
<span class="MedSmallFormText">5. Relationship of Reporting Person(s) to Issuer
|
103 |
+
</span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%">
|
104 |
+
<tr>
|
105 |
+
<td width="15%" align="center"></td>
|
106 |
+
<td width="35%" class="MedSmallFormText">Director</td>
|
107 |
+
<td width="15%" align="center"></td>
|
108 |
+
<td width="35%" class="MedSmallFormText">10% Owner</td>
|
109 |
+
</tr>
|
110 |
+
<tr>
|
111 |
+
<td align="center"><span class="FormData">X</span></td>
|
112 |
+
<td class="MedSmallFormText">Officer (give title below)</td>
|
113 |
+
<td align="center"></td>
|
114 |
+
<td class="MedSmallFormText">Other (specify below)</td>
|
115 |
+
</tr>
|
116 |
+
<tr>
|
117 |
+
<td width="15%" align="center"></td>
|
118 |
+
<td width="35%" align="left" style="color: blue">Chief Financial Officer</td>
|
119 |
+
<td width="15%" align="center"></td>
|
120 |
+
<td width="35%" align="left" style="color: blue"></td>
|
121 |
+
</tr>
|
122 |
+
</table>
|
123 |
+
</td>
|
124 |
+
</tr>
|
125 |
+
<tr><td valign="top">
|
126 |
+
<span class="MedSmallFormText">3. Date of Earliest Transaction
|
127 |
+
(Month/Day/Year)</span><br><span class="FormData">01/15/2025</span>
|
128 |
+
</td></tr>
|
129 |
+
<tr>
|
130 |
+
<td valign="top">
|
131 |
+
<span class="MedSmallFormText">4. If Amendment, Date of Original Filed
|
132 |
+
(Month/Day/Year)</span><br>
|
133 |
+
</td>
|
134 |
+
<td valign="top">
|
135 |
+
<span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
|
136 |
+
</span><table border="0" width="100%">
|
137 |
+
<tr>
|
138 |
+
<td width="15%" align="center"><span class="FormData">X</span></td>
|
139 |
+
<td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td>
|
140 |
+
</tr>
|
141 |
+
<tr>
|
142 |
+
<td width="15%" align="center"></td>
|
143 |
+
<td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td>
|
144 |
+
</tr>
|
145 |
+
</table>
|
146 |
+
</td>
|
147 |
+
</tr>
|
148 |
+
</table>
|
149 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
150 |
+
<thead>
|
151 |
+
<tr><th width="100%" valign="top" colspan="11" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned</b></th></tr>
|
152 |
+
<tr>
|
153 |
+
<th width="36%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Security (Instr.
|
154 |
+
3)
|
155 |
+
</th>
|
156 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Transaction Date
|
157 |
+
(Month/Day/Year)</th>
|
158 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2A. Deemed Execution Date, if any
|
159 |
+
(Month/Day/Year)</th>
|
160 |
+
<th width="7%" valign="top" colspan="2" align="left" class="SmallFormText">3. Transaction Code (Instr.
|
161 |
+
8)
|
162 |
+
</th>
|
163 |
+
<th width="19%" valign="top" colspan="3" align="left" class="SmallFormText">4. Securities Acquired (A) or Disposed Of (D) (Instr.
|
164 |
+
3, 4 and 5)
|
165 |
+
</th>
|
166 |
+
<th width="11%" valign="top" rowspan="2" align="left" class="SmallFormText">5.
|
167 |
+
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
168 |
+
3 and 4)
|
169 |
+
</th>
|
170 |
+
<th width="9%" valign="top" rowspan="2" align="left" class="SmallFormText">6. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
171 |
+
4)
|
172 |
+
</th>
|
173 |
+
<th width="8%" valign="top" rowspan="2" align="left" class="SmallFormText">7. Nature of Indirect Beneficial Ownership (Instr.
|
174 |
+
4)
|
175 |
+
</th>
|
176 |
+
</tr>
|
177 |
+
<tr>
|
178 |
+
<th width="4%" align="center" class="SmallFormText">Code</th>
|
179 |
+
<th width="3%" align="center" class="SmallFormText">V</th>
|
180 |
+
<th width="8%" align="center" class="SmallFormText">Amount</th>
|
181 |
+
<th width="5%" align="center" class="SmallFormText">(A) or (D)</th>
|
182 |
+
<th width="6%" align="center" class="SmallFormText">Price</th>
|
183 |
+
</tr>
|
184 |
+
</thead>
|
185 |
+
<tbody><tr>
|
186 |
+
<td align="left"><span class="FormData">Common Stock</span></td>
|
187 |
+
<td align="center"><span class="FormData">01/15/2025</span></td>
|
188 |
+
<td align="center"></td>
|
189 |
+
<td align="center"><span class="SmallFormData">S</span></td>
|
190 |
+
<td align="center"></td>
|
191 |
+
<td align="center"><span class="FormData">1,000</span></td>
|
192 |
+
<td align="center"><span class="FormData">D</span></td>
|
193 |
+
<td align="center">
|
194 |
+
<span class="FormText">$</span><span class="FormData">2.6</span>
|
195 |
+
</td>
|
196 |
+
<td align="center"><span class="FormData">458,641</span></td>
|
197 |
+
<td align="center"><span class="FormData">D</span></td>
|
198 |
+
<td align="left"></td>
|
199 |
+
</tr></tbody>
|
200 |
+
</table>
|
201 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4"><thead>
|
202 |
+
<tr><th width="100%" valign="top" colspan="16" align="center" class="FormTextC">
|
203 |
+
<b>Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b>
|
204 |
+
</th></tr>
|
205 |
+
<tr>
|
206 |
+
<th width="13%" valign="top" rowspan="2" align="left" class="SmallFormText">1. Title of Derivative Security (Instr.
|
207 |
+
3)
|
208 |
+
</th>
|
209 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Conversion or Exercise Price of Derivative Security
|
210 |
+
</th>
|
211 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3. Transaction Date
|
212 |
+
(Month/Day/Year)</th>
|
213 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3A. Deemed Execution Date, if any
|
214 |
+
(Month/Day/Year)</th>
|
215 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">4. Transaction Code (Instr.
|
216 |
+
8)
|
217 |
+
</th>
|
218 |
+
<th width="10%" valign="top" colspan="2" align="left" class="SmallFormText">5.
|
219 |
+
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
|
220 |
+
3, 4 and 5)
|
221 |
+
</th>
|
222 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">6. Date Exercisable and Expiration Date
|
223 |
+
(Month/Day/Year)</th>
|
224 |
+
<th width="17%" valign="top" colspan="2" align="left" class="SmallFormText">7. Title and Amount of Securities Underlying Derivative Security (Instr.
|
225 |
+
3 and 4)
|
226 |
+
</th>
|
227 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">8. Price of Derivative Security (Instr.
|
228 |
+
5)
|
229 |
+
</th>
|
230 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">9.
|
231 |
+
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
232 |
+
4)
|
233 |
+
</th>
|
234 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">10. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
235 |
+
4)
|
236 |
+
</th>
|
237 |
+
<th width="7%" valign="top" rowspan="2" align="left" class="SmallFormText">11. Nature of Indirect Beneficial Ownership (Instr.
|
238 |
+
4)
|
239 |
+
</th>
|
240 |
+
</tr>
|
241 |
+
<tr>
|
242 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Code</th>
|
243 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">V</th>
|
244 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(A)</th>
|
245 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(D)</th>
|
246 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">Date Exercisable</th>
|
247 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Expiration Date</th>
|
248 |
+
<th width="10%" valign="bottom" align="center" class="SmallFormText">Title</th>
|
249 |
+
<th width="7%" valign="bottom" align="center" class="SmallFormText">Amount or Number of Shares</th>
|
250 |
+
</tr>
|
251 |
+
</thead></table>
|
252 |
+
<table border="0" width="100%">
|
253 |
+
<tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr>
|
254 |
+
<tr><td class="FormText"><b>Remarks:</b></td></tr>
|
255 |
+
<tr><td class="FootnoteData"></td></tr>
|
256 |
+
</table>
|
257 |
+
<table width="100%" border="0">
|
258 |
+
<tr>
|
259 |
+
<td width="60%"></td>
|
260 |
+
<td width="20%"><u><span class="FormData">/s/ Cheriese Dickman Attorney-in-Fact for Kevin Kraus</span></u></td>
|
261 |
+
<td width="20%"><u><span class="FormData">01/16/2025</span></u></td>
|
262 |
+
</tr>
|
263 |
+
<tr>
|
264 |
+
<td></td>
|
265 |
+
<td class="MedSmallFormText">** Signature of Reporting Person</td>
|
266 |
+
<td class="MedSmallFormText">Date</td>
|
267 |
+
</tr>
|
268 |
+
<tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>
|
269 |
+
<tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person,
|
270 |
+
<i>see</i>
|
271 |
+
|
272 |
+
Instruction
|
273 |
+
4
|
274 |
+
|
275 |
+
(b)(v).</td></tr>
|
276 |
+
<tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
|
277 |
+
<i>See</i>
|
278 |
+
|
279 |
+
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>
|
280 |
+
<tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
|
281 |
+
<i>see</i>
|
282 |
+
|
283 |
+
Instruction 6 for procedure.</td></tr>
|
284 |
+
<tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>
|
285 |
+
</table>
|
286 |
+
</body>
|
287 |
+
</html>
|
downloads_2025_onwards_2/1023731_2025-01-16_8X8_INC_DE_4/1023731_2025-01-16_8X8_INC_DE_4_wk-form4_1737062003.pdf
ADDED
Binary file (45.8 kB). View file
|
|
downloads_2025_onwards_2/1023731_2025-01-16_8X8_INC_DE_4/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards_2/1023731_2025-02-04_8X8_INC_DE_8-K/1023731_2025-02-04_8X8_INC_DE_8-K_eght-20250204.htm
ADDED
@@ -0,0 +1,129 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
2 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
|
3 |
+
<html xmlns="http://www.w3.org/1999/xhtml" lang="en">
|
4 |
+
<head>
|
5 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
|
6 |
+
<meta http-equiv="Content-Security-Policy" content="upgrade-insecure-requests" />
|
7 |
+
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no" />
|
8 |
+
|
9 |
+
<link rel="shortcut icon" type="image/x-icon" href="/favicon.ico" />
|
10 |
+
<title>XBRL Viewer</title>
|
11 |
+
<script language="JavaScript">
|
12 |
+
/* <![CDATA[ */
|
13 |
+
/* Created by staff of the U.S. Securities and Exchange Commission.
|
14 |
+
* Data and content created by government employees within the scope of their employment
|
15 |
+
* are not subject to domestic copyright protection. 17 U.S.C. 105.
|
16 |
+
*
|
17 |
+
* This script checks the accession number of the document requested to determine
|
18 |
+
* the year and sequence of filing. If filed after the availability of ixviewer-plus
|
19 |
+
* this script redirects to that viewer, otherwise to a prior ixviewer in effect
|
20 |
+
* or deemed compatible with the filing.
|
21 |
+
*/
|
22 |
+
|
23 |
+
function loadViewer(ixvUrl) {
|
24 |
+
// load viewer in an iframe so the end user's browser URL is not changed
|
25 |
+
var iFrame = document.getElementById("ixvFrame");
|
26 |
+
iFrame.src = ixvUrl;
|
27 |
+
}
|
28 |
+
|
29 |
+
const url = location.href;
|
30 |
+
// url doc pattern is /Archives/edgar/data/ciknum/{10digits}{YY}{sequence}/{more params}
|
31 |
+
// uncomment one of the following urlPatterns depending on usage:
|
32 |
+
// for SEC.GOV: const urlPattern = /(\?doc=(\/Archives\/edgar\/data\/[0-9]+\/[0-9]{10}([0-9]{8})\/).*$)/;
|
33 |
+
// for Arelle GUI: const urlPattern = /(\?doc=(\/[0-9]+\/).*$)/;
|
34 |
+
const urlPattern = /(\?doc=(\/Archives\/edgar\/data\/[0-9]+\/[0-9]{10}([0-9]{8})\/).*$)/;
|
35 |
+
const ixvPlusNsPattern = /http:\/\/xbrl.sec.gov\/(ffd|sbs)\/.*$/;
|
36 |
+
var ixvUrl = null;
|
37 |
+
|
38 |
+
if (! urlPattern.test(url)) {
|
39 |
+
alert("Not an EDGAR inline XBRL document viewing request, please check URL");
|
40 |
+
// this hangs: loadViewer("/ixviewer/ix.html" + ixParams);
|
41 |
+
} else {
|
42 |
+
const match = url.match(urlPattern);
|
43 |
+
const ixParams = match[1];
|
44 |
+
const docPath = match[2];
|
45 |
+
const acsnYrSeq = match[3];
|
46 |
+
const acsnYr = Number(match[3].substring(0, 2));
|
47 |
+
let xhr = new XMLHttpRequest();
|
48 |
+
xhr.onreadystatechange = function() {
|
49 |
+
if (this.readyState == 4) {
|
50 |
+
if (this.status == 200) {
|
51 |
+
const ml = JSON.parse(this.responseText);
|
52 |
+
if (!(typeof ml === 'object' && "instance" in ml)) {
|
53 |
+
console.log("Metalinks does not have instance objects");
|
54 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
55 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
56 |
+
} else {
|
57 |
+
const numInstances = Object.keys(ml["instance"]).length;
|
58 |
+
let maxDocsPerInst = 0;
|
59 |
+
let hasIxvPlusExhibit = false;
|
60 |
+
Object.keys(ml["instance"]).forEach(instanceNames => {
|
61 |
+
let docsInInstance = instanceNames.split(" ").length;
|
62 |
+
if (docsInInstance > maxDocsPerInst)
|
63 |
+
maxDocsPerInst = docsInInstance;
|
64 |
+
if ("baseTaxonomies" in ml["instance"][instanceNames]) {
|
65 |
+
Object.keys(ml["instance"][instanceNames]["baseTaxonomies"]).forEach(baseTaxonomyUrl => {
|
66 |
+
if (ixvPlusNsPattern.test(baseTaxonomyUrl))
|
67 |
+
hasIxvPlusExhibit = true;
|
68 |
+
});
|
69 |
+
}
|
70 |
+
});
|
71 |
+
|
72 |
+
if (
|
73 |
+
(numInstances > 1 || maxDocsPerInst > 1 || hasIxvPlusExhibit || url.includes("&redline=true"))
|
74 |
+
|| acsnYr >= 25
|
75 |
+
)
|
76 |
+
loadViewer("/ixviewer-plus/ix.xhtml" + ixParams);
|
77 |
+
else
|
78 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
79 |
+
}
|
80 |
+
} else {
|
81 |
+
console.log("Unable to read MetaLinks.json for this accession");
|
82 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
83 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
84 |
+
}
|
85 |
+
}
|
86 |
+
};
|
87 |
+
xhr.ontimeout = function() {
|
88 |
+
console.log("Timeout reading MetaLinks.json for this accession");
|
89 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
90 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
91 |
+
};
|
92 |
+
xhr.open("GET", docPath + 'MetaLinks.json', true);
|
93 |
+
xhr.timeout = 2000; // milliseconds
|
94 |
+
xhr.send();
|
95 |
+
|
96 |
+
/* Arelle GUI usage: set title for tab in browser for when there are multiple tabs */
|
97 |
+
const urlTitleParamPattern = /&title=([^&]+),*$/;
|
98 |
+
if (urlTitleParamPattern.test(url)) {
|
99 |
+
const match = url.match(urlTitleParamPattern);
|
100 |
+
document.title = decodeURIComponent(match[1]);
|
101 |
+
}
|
102 |
+
|
103 |
+
/* alternative select viewer using accession number
|
104 |
+
|
105 |
+
const acsnYrSeq = match[3];
|
106 |
+
if (acsnYrSeq > "24905000") {
|
107 |
+
loadViewer(docPath + "ixbrlviewer.xhtml");
|
108 |
+
} else if (acsnYrSeq > "23905000") {
|
109 |
+
loadViewer("/ixviewer-plus/ix.xhtml" + ixParams);
|
110 |
+
} else {
|
111 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
112 |
+
}
|
113 |
+
|
114 |
+
*/
|
115 |
+
}
|
116 |
+
/* ]]> */
|
117 |
+
</script>
|
118 |
+
</head>
|
119 |
+
|
120 |
+
<body style="margin: 0">
|
121 |
+
<noscript>
|
122 |
+
Please enable JavaScript to use the EDGAR Inline XBRL Viewer.
|
123 |
+
</noscript>
|
124 |
+
<iframe id="ixvFrame"
|
125 |
+
title="Inline XBRL Viewer"
|
126 |
+
style="position: absolute; height: 100%; width: 100%; border: none"
|
127 |
+
/>
|
128 |
+
</body>
|
129 |
+
</html>
|
downloads_2025_onwards_2/1023731_2025-02-04_8X8_INC_DE_8-K/1023731_2025-02-04_8X8_INC_DE_8-K_eght-20250204.pdf
ADDED
Binary file (1.21 kB). View file
|
|
downloads_2025_onwards_2/1023731_2025-02-04_8X8_INC_DE_8-K/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards_2/1023731_2025-02-05_8X8_INC_DE_10-Q/1023731_2025-02-05_8X8_INC_DE_10-Q_eght-20241231.htm
ADDED
@@ -0,0 +1,129 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
2 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
|
3 |
+
<html xmlns="http://www.w3.org/1999/xhtml" lang="en">
|
4 |
+
<head>
|
5 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
|
6 |
+
<meta http-equiv="Content-Security-Policy" content="upgrade-insecure-requests" />
|
7 |
+
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no" />
|
8 |
+
|
9 |
+
<link rel="shortcut icon" type="image/x-icon" href="/favicon.ico" />
|
10 |
+
<title>XBRL Viewer</title>
|
11 |
+
<script language="JavaScript">
|
12 |
+
/* <![CDATA[ */
|
13 |
+
/* Created by staff of the U.S. Securities and Exchange Commission.
|
14 |
+
* Data and content created by government employees within the scope of their employment
|
15 |
+
* are not subject to domestic copyright protection. 17 U.S.C. 105.
|
16 |
+
*
|
17 |
+
* This script checks the accession number of the document requested to determine
|
18 |
+
* the year and sequence of filing. If filed after the availability of ixviewer-plus
|
19 |
+
* this script redirects to that viewer, otherwise to a prior ixviewer in effect
|
20 |
+
* or deemed compatible with the filing.
|
21 |
+
*/
|
22 |
+
|
23 |
+
function loadViewer(ixvUrl) {
|
24 |
+
// load viewer in an iframe so the end user's browser URL is not changed
|
25 |
+
var iFrame = document.getElementById("ixvFrame");
|
26 |
+
iFrame.src = ixvUrl;
|
27 |
+
}
|
28 |
+
|
29 |
+
const url = location.href;
|
30 |
+
// url doc pattern is /Archives/edgar/data/ciknum/{10digits}{YY}{sequence}/{more params}
|
31 |
+
// uncomment one of the following urlPatterns depending on usage:
|
32 |
+
// for SEC.GOV: const urlPattern = /(\?doc=(\/Archives\/edgar\/data\/[0-9]+\/[0-9]{10}([0-9]{8})\/).*$)/;
|
33 |
+
// for Arelle GUI: const urlPattern = /(\?doc=(\/[0-9]+\/).*$)/;
|
34 |
+
const urlPattern = /(\?doc=(\/Archives\/edgar\/data\/[0-9]+\/[0-9]{10}([0-9]{8})\/).*$)/;
|
35 |
+
const ixvPlusNsPattern = /http:\/\/xbrl.sec.gov\/(ffd|sbs)\/.*$/;
|
36 |
+
var ixvUrl = null;
|
37 |
+
|
38 |
+
if (! urlPattern.test(url)) {
|
39 |
+
alert("Not an EDGAR inline XBRL document viewing request, please check URL");
|
40 |
+
// this hangs: loadViewer("/ixviewer/ix.html" + ixParams);
|
41 |
+
} else {
|
42 |
+
const match = url.match(urlPattern);
|
43 |
+
const ixParams = match[1];
|
44 |
+
const docPath = match[2];
|
45 |
+
const acsnYrSeq = match[3];
|
46 |
+
const acsnYr = Number(match[3].substring(0, 2));
|
47 |
+
let xhr = new XMLHttpRequest();
|
48 |
+
xhr.onreadystatechange = function() {
|
49 |
+
if (this.readyState == 4) {
|
50 |
+
if (this.status == 200) {
|
51 |
+
const ml = JSON.parse(this.responseText);
|
52 |
+
if (!(typeof ml === 'object' && "instance" in ml)) {
|
53 |
+
console.log("Metalinks does not have instance objects");
|
54 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
55 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
56 |
+
} else {
|
57 |
+
const numInstances = Object.keys(ml["instance"]).length;
|
58 |
+
let maxDocsPerInst = 0;
|
59 |
+
let hasIxvPlusExhibit = false;
|
60 |
+
Object.keys(ml["instance"]).forEach(instanceNames => {
|
61 |
+
let docsInInstance = instanceNames.split(" ").length;
|
62 |
+
if (docsInInstance > maxDocsPerInst)
|
63 |
+
maxDocsPerInst = docsInInstance;
|
64 |
+
if ("baseTaxonomies" in ml["instance"][instanceNames]) {
|
65 |
+
Object.keys(ml["instance"][instanceNames]["baseTaxonomies"]).forEach(baseTaxonomyUrl => {
|
66 |
+
if (ixvPlusNsPattern.test(baseTaxonomyUrl))
|
67 |
+
hasIxvPlusExhibit = true;
|
68 |
+
});
|
69 |
+
}
|
70 |
+
});
|
71 |
+
|
72 |
+
if (
|
73 |
+
(numInstances > 1 || maxDocsPerInst > 1 || hasIxvPlusExhibit || url.includes("&redline=true"))
|
74 |
+
|| acsnYr >= 25
|
75 |
+
)
|
76 |
+
loadViewer("/ixviewer-plus/ix.xhtml" + ixParams);
|
77 |
+
else
|
78 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
79 |
+
}
|
80 |
+
} else {
|
81 |
+
console.log("Unable to read MetaLinks.json for this accession");
|
82 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
83 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
84 |
+
}
|
85 |
+
}
|
86 |
+
};
|
87 |
+
xhr.ontimeout = function() {
|
88 |
+
console.log("Timeout reading MetaLinks.json for this accession");
|
89 |
+
// Unable to read MetaLinks.json, use 23.2 ixviewer
|
90 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
91 |
+
};
|
92 |
+
xhr.open("GET", docPath + 'MetaLinks.json', true);
|
93 |
+
xhr.timeout = 2000; // milliseconds
|
94 |
+
xhr.send();
|
95 |
+
|
96 |
+
/* Arelle GUI usage: set title for tab in browser for when there are multiple tabs */
|
97 |
+
const urlTitleParamPattern = /&title=([^&]+),*$/;
|
98 |
+
if (urlTitleParamPattern.test(url)) {
|
99 |
+
const match = url.match(urlTitleParamPattern);
|
100 |
+
document.title = decodeURIComponent(match[1]);
|
101 |
+
}
|
102 |
+
|
103 |
+
/* alternative select viewer using accession number
|
104 |
+
|
105 |
+
const acsnYrSeq = match[3];
|
106 |
+
if (acsnYrSeq > "24905000") {
|
107 |
+
loadViewer(docPath + "ixbrlviewer.xhtml");
|
108 |
+
} else if (acsnYrSeq > "23905000") {
|
109 |
+
loadViewer("/ixviewer-plus/ix.xhtml" + ixParams);
|
110 |
+
} else {
|
111 |
+
loadViewer("/ixviewer/ix.html" + ixParams);
|
112 |
+
}
|
113 |
+
|
114 |
+
*/
|
115 |
+
}
|
116 |
+
/* ]]> */
|
117 |
+
</script>
|
118 |
+
</head>
|
119 |
+
|
120 |
+
<body style="margin: 0">
|
121 |
+
<noscript>
|
122 |
+
Please enable JavaScript to use the EDGAR Inline XBRL Viewer.
|
123 |
+
</noscript>
|
124 |
+
<iframe id="ixvFrame"
|
125 |
+
title="Inline XBRL Viewer"
|
126 |
+
style="position: absolute; height: 100%; width: 100%; border: none"
|
127 |
+
/>
|
128 |
+
</body>
|
129 |
+
</html>
|
downloads_2025_onwards_2/1023731_2025-02-05_8X8_INC_DE_10-Q/1023731_2025-02-05_8X8_INC_DE_10-Q_eght-20241231.pdf
ADDED
Binary file (1.21 kB). View file
|
|
downloads_2025_onwards_2/1023731_2025-02-05_8X8_INC_DE_10-Q/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards_2/1023731_2025-02-11_8X8_INC_DE_144/1023731_2025-02-11_8X8_INC_DE_144_primary_doc.html
ADDED
@@ -0,0 +1,140 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
|
2 |
+
<html xmlns:p="http://www.sec.gov/edgar/ownership" xmlns:p1="http://www.sec.gov/edgar/common"><head><meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1"><link rel="stylesheet" type="text/css" href="/css/SDR_print.css"><style type="text/css">
|
3 |
+
.fakeTextBox {
|
4 |
+
border-top: 2px solid #999;
|
5 |
+
border-right: 1px solid #ccc;
|
6 |
+
border-bottom: 1px solid #ccc;
|
7 |
+
border-left: 2px solid #999;
|
8 |
+
padding: 2px;
|
9 |
+
_width: 800px;
|
10 |
+
height: auto;
|
11 |
+
min-width: 200px;
|
12 |
+
min-height: 50px;
|
13 |
+
word-wrap: break-word;
|
14 |
+
font-size: 0.9em;
|
15 |
+
color: blue;
|
16 |
+
}
|
17 |
+
</style><style type="text/css">
|
18 |
+
table.tableClass { border: solid black;
|
19 |
+
border-top-width: 1;
|
20 |
+
border-right-width: 1;
|
21 |
+
border-bottom-width: 1;
|
22 |
+
border-left-width: 1;
|
23 |
+
table-layout:fixed;
|
24 |
+
}
|
25 |
+
th.tableClassLeft { border: solid black;
|
26 |
+
border-top-width: 0px;
|
27 |
+
border-right-width: 0px;
|
28 |
+
border-bottom-width: 1px;
|
29 |
+
border-left-width: 1px;
|
30 |
+
padding: 2px;
|
31 |
+
}
|
32 |
+
th.tableClassRight { border: solid black;
|
33 |
+
border-top-width: 0px;
|
34 |
+
border-right-width: 1px;
|
35 |
+
border-bottom-width: 1px;
|
36 |
+
border-left-width: 0;
|
37 |
+
padding: 2px;
|
38 |
+
}
|
39 |
+
th.tableClass { border: solid black;
|
40 |
+
border-top-width: 0px;
|
41 |
+
border-right-width: 1px;
|
42 |
+
border-bottom-width: 1px;
|
43 |
+
border-left-width: 1px;
|
44 |
+
padding: 2px;
|
45 |
+
}
|
46 |
+
td.tableClassLeft { border: solid black;
|
47 |
+
border-top-width: 0px;
|
48 |
+
border-right-width: 0px;
|
49 |
+
border-bottom-width: 1px;
|
50 |
+
border-left-width: 1px;
|
51 |
+
font-size: 0.9em;
|
52 |
+
color: blue;
|
53 |
+
word-wrap: break-word;
|
54 |
+
}
|
55 |
+
td.tableClassRight { border: solid black;
|
56 |
+
border-top-width: 0px;
|
57 |
+
border-right-width: 1px;
|
58 |
+
border-bottom-width: 1px;
|
59 |
+
border-left-width: 0;
|
60 |
+
font-size: 0.9em;
|
61 |
+
color: blue;
|
62 |
+
word-wrap: break-word;
|
63 |
+
}
|
64 |
+
td.tableClass { border: solid black;
|
65 |
+
border-top-width: 0px;
|
66 |
+
border-right-width: 1px;
|
67 |
+
border-bottom-width: 1px;
|
68 |
+
border-left-width: 1px;
|
69 |
+
font-size: 0.9em;
|
70 |
+
color: blue;
|
71 |
+
word-wrap: break-word;
|
72 |
+
}
|
73 |
+
tr.tableClass { border: solid black;
|
74 |
+
border-top-width: 1px;
|
75 |
+
border-right-width: 1px;
|
76 |
+
border-bottom-width: 1px;
|
77 |
+
border-left-width: 1px;
|
78 |
+
}
|
79 |
+
tr.tableClassWithBg { border: solid black;
|
80 |
+
border-top-width: 0;
|
81 |
+
border-right-width: 1;
|
82 |
+
border-bottom-width: 1;
|
83 |
+
border-left-width: 0;
|
84 |
+
background-color: #e0e0ff
|
85 |
+
}
|
86 |
+
</style></head><body lang="en-US" text="#000000" bgcolor="#ffffff">
|
87 |
+
<div class="contentwrapper"><table role="presentation" id="header"><tr><td class="title">Form 144 Filer Information</td><td rowspan="2" class="center">
|
88 |
+
UNITED STATES
|
89 |
+
<br>
|
90 |
+
SECURITIES AND EXCHANGE COMMISSION
|
91 |
+
<br>
|
92 |
+
Washington, D.C. 20549
|
93 |
+
<br><br>
|
94 |
+
Form 144
|
95 |
+
<br><br><div style="font-size:.9em;">
|
96 |
+
NOTICE OF PROPOSED SALE OF SECURITIES
|
97 |
+
<br>
|
98 |
+
PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
|
99 |
+
</div></td><td></td></tr><tr><td class="side" style="text-align: center;vertical-align:middle"><p>
|
100 |
+
FORM 144</p></td><td width="25%"></td></tr></table></div><div id="info"><div class="contentwrapper"><div class="content"><h1>144: Filer Information</h1><table role="presentation" class="filerInformation"><tr><td class="label">Filer CIK</td><td><div class="fakeBox">0001956959</div></td></tr><tr><td class="label">Filer CCC</td><td><div class="fakeBox">XXXXXXXX</div></td></tr><tr><td class="label">
|
101 |
+
Is this a LIVE or TEST Filing?
|
102 |
+
</td><td><img src="/Images/radio-checked.jpg" alt="Radio button checked"> LIVE
|
103 |
+
<img src="/Images/radio-unchecked.jpg" alt="Radio button not checked"> TEST
|
104 |
+
</td></tr><tr><td><h4><em>Submission Contact Information</em></h4></td></tr><tr><td class="label">Name</td><td><div class="fakeBox"></div></td></tr><tr><td class="label">Phone</td><td><div class="fakeBox"></div></td></tr><tr><td class="label">E-Mail Address</td><td><div class="fakeBox"></div></td></tr></table></div></div></div>
|
105 |
+
<div class="content"><h1>144: Issuer Information</h1><div class="form1"><table role="presentation" class="filingInformation" id="submissionInformation"><tr><td class="label">Name of Issuer</td><td><div class="fakeBox">8 X 8 INC</div></td></tr><tr><td class="label">SEC File Number</td><td><div class="fakeBox">001-38312</div></td></tr><tr><td class="label">Address of Issuer</td><td><div class="fakeBox">675 Creekside Way <br>Campbell<br>
|
106 |
+
CALIFORNIA
|
107 |
+
<br>95008</div></td></tr><tr><td class="label">Phone</td><td><div class="fakeBox">4087271885</div></td></tr><tr><td class="label">Name of Person for Whose Account the Securities are To Be Sold</td><td><div class="fakeBox">LAURENCE DENNY</div></td></tr><tr><td colspan="2"><div class="information" style="text-align:justify">
|
108 |
+
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account
|
109 |
+
the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given
|
110 |
+
as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales
|
111 |
+
for the account of the person filing this notice.
|
112 |
+
<br><br></div></td></tr><tr><td class="label">Relationship to Issuer</td><td><div class="fakeBox">Officer</div></td></tr></table></div><h1>144: Securities Information</h1><div class="form1"><table role="presentation" class="tableClass" id="submissionInformation"><tr width="100%" class="tableClassWithBg"><th width="23%" class="tableClass">Title of the Class of Securities To Be Sold</th><th width="22%" class="tableClass">Name and Address of the Broker</th><th width="11%" class="tableClass">Number of Shares or Other Units To Be Sold</th><th width="12%" class="tableClass">Aggregate Market Value</th><th width="11%" class="tableClass">Number of Shares or Other Units Outstanding</th><th width="8%" class="tableClass">Approximate Date of Sale</th><th width="12%" class="tableClass">Name the Securities Exchange</th></tr><tr width="100%" class="tableClass"><td width="23%" class="tableClass">Common</td><td width="22%" class="tableClass"><div>Morgan Stanley Smith Barney LLC Executive Financial Services<br>1 New York Plaza<br>8th Floor<br>New York
|
113 |
+
�
|
114 |
+
NY
|
115 |
+
�
|
116 |
+
10004</div></td><td width="11%" class="tableClass">10000</td><td width="12%" class="tableClass">28600.00</td><td width="11%" class="tableClass">131693671</td><td width="8%" class="tableClass">02/11/2025</td><td width="12%" class="tableClass"><div>NASDAQ</div></td></tr></table></div><br><br><div class="information" style="text-align:justify">
|
117 |
+
Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment
|
118 |
+
of all or any part of the purchase price or other consideration therefor:
|
119 |
+
</div><h1>144: Securities To Be Sold</h1><div class="form1"><table role="presentation" class="tableClass" id="securitiesToBeSold"><tr width="100%" class="tableClassWithBg"><th width="14%" class="tableClassRight">Title of the Class</th><th width="8%" class="tableClass">Date you Acquired</th><th width="16%" class="tableClass">Nature of Acquisition Transaction</th><th width="14%" class="tableClass">Name of Person from Whom Acquired</th><th width="4%" class="tableClass">Is this a Gift?</th><th width="8%" class="tableClass">Date Donor Acquired</th><th width="12%" class="tableClass">Amount of Securities Acquired</th><th width="8%" class="tableClass">Date of Payment</th><th width="16%" class="tableClassLeft">Nature of Payment <b>*</b></th></tr><tr width="100%" class="tableClass"><td width="14%" class="tableClassRight">Common</td><td width="8%" class="tableClass">02/09/2025</td><td width="16%" class="tableClass">Employee Stock Purchase Plan</td><td width="14%" class="tableClass">Issuer</td><td width="4%" class="tableClass"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"></td><td width="8%" class="tableClass"></td><td width="12%" class="tableClass">10000</td><td width="8%" class="tableClass">02/09/2025</td><td width="16%" class="tableClassLeft">Cash</td></tr></table><br><div class="information" style="text-align:justify"><b>*</b> If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note
|
120 |
+
thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made
|
121 |
+
in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.
|
122 |
+
</div><br></div><br><br><div class="information" style="text-align:justify">
|
123 |
+
Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.
|
124 |
+
</div><h1>144: Securities Sold During The Past 3 Months</h1><div class="form1"><table role="presentation" class="tableClass" id="submissionInformation"><tr width="100%" class="tableClassWithBg"><th width="33%" class="tableClass">Name and Address of Seller</th><th width="33%" class="tableClass">Title of Securities Sold</th><th width="8%" class="tableClass">Date of Sale</th><th width="12%" class="tableClass">Amount of Securities Sold</th><th width="14%" class="tableClass">Gross Proceeds</th></tr><tr><td width="33%" class="tableClass">10b5-1 Sales for LAURENCE A DENNY<br>675 Creekside Way <br>Campbell
|
125 |
+
�
|
126 |
+
CA
|
127 |
+
�
|
128 |
+
95008</td><td width="33%" class="tableClass">Common</td><td width="8%" class="tableClass">11/22/2024</td><td width="12%" class="tableClass">23773</td><td width="14%" class="tableClass">71492.54</td></tr><tr><td width="33%" class="tableClass">10b5-1 Sales for LAURENCE A DENNY<br>675 Creekside Way <br>Campbell
|
129 |
+
�
|
130 |
+
CA
|
131 |
+
�
|
132 |
+
95008</td><td width="33%" class="tableClass">Common</td><td width="8%" class="tableClass">11/21/2024</td><td width="12%" class="tableClass">11227</td><td width="14%" class="tableClass">33681.00</td></tr></table></div><h1>144: Remarks and Signature</h1><div class="form1"><table role="presentation" class="filingInformation" id="submissionInformation"><tr><td class="label">Remarks</td><td><div class="fakeBox"></div></td></tr><tr><td class="label">Date of Notice</td><td><div class="fakeBox">02/11/2025</div></td></tr><tr><td class="label">Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1</td><td><div class="fakeBox">08/19/2024</div></td></tr><tr><td colspan="2"><h4><em>ATTENTION:</em></h4></td></tr><tr><td colspan="2" style="text-align:justify">
|
133 |
+
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing
|
134 |
+
this notice that he does not know any material adverse information in regard to the current and prospective
|
135 |
+
operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has
|
136 |
+
adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by
|
137 |
+
signing the form and indicating the date that the plan was adopted or the instruction given, that person makes
|
138 |
+
such representation as of the plan adoption or instruction date.
|
139 |
+
</td></tr><tr><td class="label">Signature</td><td><div class="fakeBox">/s/ Laurence Denny</div></td></tr><tr><td colspan="2"><h4 style="text-align:center"><em>ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)</em></h4></td></tr></table></div></div>
|
140 |
+
</body></html>
|
downloads_2025_onwards_2/1023731_2025-02-11_8X8_INC_DE_144/1023731_2025-02-11_8X8_INC_DE_144_primary_doc.pdf
ADDED
Binary file (34.2 kB). View file
|
|
downloads_2025_onwards_2/1023731_2025-02-11_8X8_INC_DE_144/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards_2/1023731_2025-02-11_8X8_INC_DE_144/images/page_2.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards_2/1023731_2025-02-11_8X8_INC_DE_4/1023731_2025-02-11_8X8_INC_DE_4_wk-form4_1739313863.html
ADDED
@@ -0,0 +1,290 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
|
2 |
+
<html>
|
3 |
+
<head>
|
4 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
|
5 |
+
<title>SEC FORM
|
6 |
+
4</title>
|
7 |
+
<style type="text/css">
|
8 |
+
.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
|
9 |
+
.FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
|
10 |
+
.FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
|
11 |
+
.SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
|
12 |
+
.FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
|
13 |
+
.FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
|
14 |
+
.FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
|
15 |
+
.FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
|
16 |
+
.FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
|
17 |
+
.FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
|
18 |
+
.FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
19 |
+
.FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
20 |
+
.SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
21 |
+
.SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
|
22 |
+
.SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
|
23 |
+
.MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
24 |
+
.FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
25 |
+
.FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
|
26 |
+
.FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
27 |
+
.FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
|
28 |
+
.SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif;
|
29 |
+
font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
|
30 |
+
.FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
31 |
+
.CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid; border-color: black:}
|
32 |
+
body {background: white;}
|
33 |
+
</style>
|
34 |
+
</head>
|
35 |
+
<body>SEC Form 4
|
36 |
+
<table width="100%" border="0" cellspacing="0" cellpadding="4">
|
37 |
+
<tr>
|
38 |
+
<td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 4</td>
|
39 |
+
<td rowspan="2" width="60%" valign="middle" align="center">
|
40 |
+
<span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span>
|
41 |
+
</td>
|
42 |
+
<td rowspan="2" width="20%" valign="top" align="center"><table width="100%" border="1" summary="OMB Approval Status Box">
|
43 |
+
<tr><td class="FormTextC">OMB APPROVAL</td></tr>
|
44 |
+
<tr><td><table width="100%" border="0" summary="OMB Interior Box">
|
45 |
+
<tr>
|
46 |
+
<td class="SmallFormText" colspan="3">OMB Number:</td>
|
47 |
+
<td class="SmallFormTextR">3235-0287</td>
|
48 |
+
</tr>
|
49 |
+
<tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr>
|
50 |
+
<tr>
|
51 |
+
<td class="SmallFormText" colspan="3">hours per response:</td>
|
52 |
+
<td class="SmallFormTextR">0.5</td>
|
53 |
+
</tr>
|
54 |
+
</table></td></tr>
|
55 |
+
</table></td>
|
56 |
+
</tr>
|
57 |
+
<tr valign="middle">
|
58 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td> </td></tr></table></td>
|
59 |
+
<td class="SmallFormText">Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
|
60 |
+
<i>See</i>
|
61 |
+
|
62 |
+
Instruction 1(b).</td>
|
63 |
+
</tr>
|
64 |
+
<tr valign="middle">
|
65 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td><span class="FormData">X</span></td></tr></table></td>
|
66 |
+
<td class="SmallFormText">Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. </td>
|
67 |
+
</tr>
|
68 |
+
</table>
|
69 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
70 |
+
<tr>
|
71 |
+
<td rowspan="4" width="35%" valign="top">
|
72 |
+
<span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001956959">Denny Laurence</a></td></tr></table>
|
73 |
+
<hr width="98%">
|
74 |
+
<table border="0" width="100%"><tr>
|
75 |
+
<td width="33%" class="MedSmallFormText">(Last)</td>
|
76 |
+
<td width="33%" class="MedSmallFormText">(First)</td>
|
77 |
+
<td width="33%" class="MedSmallFormText">(Middle)</td>
|
78 |
+
</tr></table>
|
79 |
+
<table border="0" width="100%">
|
80 |
+
<tr><td><span class="FormData">C/O 8X8 INC. 675 CREEKSIDE WAY</span></td></tr>
|
81 |
+
<tr><td><span class="FormData"></span></td></tr>
|
82 |
+
</table>
|
83 |
+
<hr width="98%">
|
84 |
+
<span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr>
|
85 |
+
<td width="33%"><span class="FormData">CAMPBELL</span></td>
|
86 |
+
<td width="33%"><span class="FormData">CA</span></td>
|
87 |
+
<td width="33%"><span class="FormData">95008</span></td>
|
88 |
+
</tr></table>
|
89 |
+
<hr width="98%">
|
90 |
+
<table border="0" width="100%"><tr>
|
91 |
+
<td width="33%" class="MedSmallFormText">(City)</td>
|
92 |
+
<td width="33%" class="MedSmallFormText">(State)</td>
|
93 |
+
<td width="33%" class="MedSmallFormText">(Zip)</td>
|
94 |
+
</tr></table>
|
95 |
+
</td>
|
96 |
+
<td width="35%" valign="top">
|
97 |
+
<span class="MedSmallFormText">2. Issuer Name <b>and</b> Ticker or Trading Symbol
|
98 |
+
</span><br><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001023731">8X8 INC /DE/</a>
|
99 |
+
[ <span class="FormData">EGHT</span> ]
|
100 |
+
</td>
|
101 |
+
<td rowspan="2" valign="top">
|
102 |
+
<span class="MedSmallFormText">5. Relationship of Reporting Person(s) to Issuer
|
103 |
+
</span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%">
|
104 |
+
<tr>
|
105 |
+
<td width="15%" align="center"></td>
|
106 |
+
<td width="35%" class="MedSmallFormText">Director</td>
|
107 |
+
<td width="15%" align="center"></td>
|
108 |
+
<td width="35%" class="MedSmallFormText">10% Owner</td>
|
109 |
+
</tr>
|
110 |
+
<tr>
|
111 |
+
<td align="center"><span class="FormData">X</span></td>
|
112 |
+
<td class="MedSmallFormText">Officer (give title below)</td>
|
113 |
+
<td align="center"></td>
|
114 |
+
<td class="MedSmallFormText">Other (specify below)</td>
|
115 |
+
</tr>
|
116 |
+
<tr>
|
117 |
+
<td width="15%" align="center"></td>
|
118 |
+
<td width="35%" align="left" style="color: blue">Chief Legal Officer</td>
|
119 |
+
<td width="15%" align="center"></td>
|
120 |
+
<td width="35%" align="left" style="color: blue"></td>
|
121 |
+
</tr>
|
122 |
+
</table>
|
123 |
+
</td>
|
124 |
+
</tr>
|
125 |
+
<tr><td valign="top">
|
126 |
+
<span class="MedSmallFormText">3. Date of Earliest Transaction
|
127 |
+
(Month/Day/Year)</span><br><span class="FormData">02/11/2025</span>
|
128 |
+
</td></tr>
|
129 |
+
<tr>
|
130 |
+
<td valign="top">
|
131 |
+
<span class="MedSmallFormText">4. If Amendment, Date of Original Filed
|
132 |
+
(Month/Day/Year)</span><br>
|
133 |
+
</td>
|
134 |
+
<td valign="top">
|
135 |
+
<span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
|
136 |
+
</span><table border="0" width="100%">
|
137 |
+
<tr>
|
138 |
+
<td width="15%" align="center"><span class="FormData">X</span></td>
|
139 |
+
<td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td>
|
140 |
+
</tr>
|
141 |
+
<tr>
|
142 |
+
<td width="15%" align="center"></td>
|
143 |
+
<td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td>
|
144 |
+
</tr>
|
145 |
+
</table>
|
146 |
+
</td>
|
147 |
+
</tr>
|
148 |
+
</table>
|
149 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
150 |
+
<thead>
|
151 |
+
<tr><th width="100%" valign="top" colspan="11" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned</b></th></tr>
|
152 |
+
<tr>
|
153 |
+
<th width="36%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Security (Instr.
|
154 |
+
3)
|
155 |
+
</th>
|
156 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Transaction Date
|
157 |
+
(Month/Day/Year)</th>
|
158 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2A. Deemed Execution Date, if any
|
159 |
+
(Month/Day/Year)</th>
|
160 |
+
<th width="7%" valign="top" colspan="2" align="left" class="SmallFormText">3. Transaction Code (Instr.
|
161 |
+
8)
|
162 |
+
</th>
|
163 |
+
<th width="19%" valign="top" colspan="3" align="left" class="SmallFormText">4. Securities Acquired (A) or Disposed Of (D) (Instr.
|
164 |
+
3, 4 and 5)
|
165 |
+
</th>
|
166 |
+
<th width="11%" valign="top" rowspan="2" align="left" class="SmallFormText">5.
|
167 |
+
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
168 |
+
3 and 4)
|
169 |
+
</th>
|
170 |
+
<th width="9%" valign="top" rowspan="2" align="left" class="SmallFormText">6. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
171 |
+
4)
|
172 |
+
</th>
|
173 |
+
<th width="8%" valign="top" rowspan="2" align="left" class="SmallFormText">7. Nature of Indirect Beneficial Ownership (Instr.
|
174 |
+
4)
|
175 |
+
</th>
|
176 |
+
</tr>
|
177 |
+
<tr>
|
178 |
+
<th width="4%" align="center" class="SmallFormText">Code</th>
|
179 |
+
<th width="3%" align="center" class="SmallFormText">V</th>
|
180 |
+
<th width="8%" align="center" class="SmallFormText">Amount</th>
|
181 |
+
<th width="5%" align="center" class="SmallFormText">(A) or (D)</th>
|
182 |
+
<th width="6%" align="center" class="SmallFormText">Price</th>
|
183 |
+
</tr>
|
184 |
+
</thead>
|
185 |
+
<tbody><tr>
|
186 |
+
<td align="left"><span class="FormData">Common Stock</span></td>
|
187 |
+
<td align="center"><span class="FormData">02/11/2025</span></td>
|
188 |
+
<td align="center"></td>
|
189 |
+
<td align="center"><span class="SmallFormData">S</span></td>
|
190 |
+
<td align="center"></td>
|
191 |
+
<td align="center"><span class="FormData">10,000</span></td>
|
192 |
+
<td align="center"><span class="FormData">D</span></td>
|
193 |
+
<td align="center">
|
194 |
+
<span class="FormText">$</span><span class="FormData">3</span>
|
195 |
+
</td>
|
196 |
+
<td align="center">
|
197 |
+
<span class="FormData">233,791</span><span class="FootnoteData"><sup>(1)</sup></span>
|
198 |
+
</td>
|
199 |
+
<td align="center"><span class="FormData">D</span></td>
|
200 |
+
<td align="left"></td>
|
201 |
+
</tr></tbody>
|
202 |
+
</table>
|
203 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4"><thead>
|
204 |
+
<tr><th width="100%" valign="top" colspan="16" align="center" class="FormTextC">
|
205 |
+
<b>Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b>
|
206 |
+
</th></tr>
|
207 |
+
<tr>
|
208 |
+
<th width="13%" valign="top" rowspan="2" align="left" class="SmallFormText">1. Title of Derivative Security (Instr.
|
209 |
+
3)
|
210 |
+
</th>
|
211 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Conversion or Exercise Price of Derivative Security
|
212 |
+
</th>
|
213 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3. Transaction Date
|
214 |
+
(Month/Day/Year)</th>
|
215 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3A. Deemed Execution Date, if any
|
216 |
+
(Month/Day/Year)</th>
|
217 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">4. Transaction Code (Instr.
|
218 |
+
8)
|
219 |
+
</th>
|
220 |
+
<th width="10%" valign="top" colspan="2" align="left" class="SmallFormText">5.
|
221 |
+
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
|
222 |
+
3, 4 and 5)
|
223 |
+
</th>
|
224 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">6. Date Exercisable and Expiration Date
|
225 |
+
(Month/Day/Year)</th>
|
226 |
+
<th width="17%" valign="top" colspan="2" align="left" class="SmallFormText">7. Title and Amount of Securities Underlying Derivative Security (Instr.
|
227 |
+
3 and 4)
|
228 |
+
</th>
|
229 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">8. Price of Derivative Security (Instr.
|
230 |
+
5)
|
231 |
+
</th>
|
232 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">9.
|
233 |
+
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
234 |
+
4)
|
235 |
+
</th>
|
236 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">10. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
237 |
+
4)
|
238 |
+
</th>
|
239 |
+
<th width="7%" valign="top" rowspan="2" align="left" class="SmallFormText">11. Nature of Indirect Beneficial Ownership (Instr.
|
240 |
+
4)
|
241 |
+
</th>
|
242 |
+
</tr>
|
243 |
+
<tr>
|
244 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Code</th>
|
245 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">V</th>
|
246 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(A)</th>
|
247 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(D)</th>
|
248 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">Date Exercisable</th>
|
249 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Expiration Date</th>
|
250 |
+
<th width="10%" valign="bottom" align="center" class="SmallFormText">Title</th>
|
251 |
+
<th width="7%" valign="bottom" align="center" class="SmallFormText">Amount or Number of Shares</th>
|
252 |
+
</tr>
|
253 |
+
</thead></table>
|
254 |
+
<table border="0" width="100%">
|
255 |
+
<tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr>
|
256 |
+
<tr><td class="FootnoteData">1. Includes 10,000 shares purchased on February 9, 2025 pursuant to the company's Employee Stock Purchase Plan (ESPP).</td></tr>
|
257 |
+
<tr><td class="FormText"><b>Remarks:</b></td></tr>
|
258 |
+
<tr><td class="FootnoteData"></td></tr>
|
259 |
+
</table>
|
260 |
+
<table width="100%" border="0">
|
261 |
+
<tr>
|
262 |
+
<td width="60%"></td>
|
263 |
+
<td width="20%"><u><span class="FormData">/s/ Cheriese Dickman Attorney-in-Fact for Laurence Denny</span></u></td>
|
264 |
+
<td width="20%"><u><span class="FormData">02/11/2025</span></u></td>
|
265 |
+
</tr>
|
266 |
+
<tr>
|
267 |
+
<td></td>
|
268 |
+
<td class="MedSmallFormText">** Signature of Reporting Person</td>
|
269 |
+
<td class="MedSmallFormText">Date</td>
|
270 |
+
</tr>
|
271 |
+
<tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>
|
272 |
+
<tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person,
|
273 |
+
<i>see</i>
|
274 |
+
|
275 |
+
Instruction
|
276 |
+
4
|
277 |
+
|
278 |
+
(b)(v).</td></tr>
|
279 |
+
<tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
|
280 |
+
<i>See</i>
|
281 |
+
|
282 |
+
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>
|
283 |
+
<tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
|
284 |
+
<i>see</i>
|
285 |
+
|
286 |
+
Instruction 6 for procedure.</td></tr>
|
287 |
+
<tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>
|
288 |
+
</table>
|
289 |
+
</body>
|
290 |
+
</html>
|
downloads_2025_onwards_2/1023731_2025-02-11_8X8_INC_DE_4/1023731_2025-02-11_8X8_INC_DE_4_wk-form4_1739313863.pdf
ADDED
Binary file (46.8 kB). View file
|
|
downloads_2025_onwards_2/1023731_2025-02-11_8X8_INC_DE_4/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards_2/1023731_2025-02-14_8X8_INC_DE_SCHEDULE_13G/1023731_2025-02-14_8X8_INC_DE_SCHEDULE_13G_primary_doc.html
ADDED
@@ -0,0 +1,413 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
|
2 |
+
<html xmlns:p="http://www.sec.gov/edgar/schedule13g" xmlns:p1="http://www.sec.gov/edgar/common"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><link rel="stylesheet" type="text/css" href="/css/SDR_print.css"><style type="text/css">
|
3 |
+
.fakeTextBox {
|
4 |
+
border-top: 2px solid #999;
|
5 |
+
border-right: 1px solid #ccc;
|
6 |
+
border-bottom: 1px solid #ccc;
|
7 |
+
border-left: 2px solid #999;
|
8 |
+
padding: 2px;
|
9 |
+
_width: 800px;
|
10 |
+
height: auto;
|
11 |
+
min-width: 200px;
|
12 |
+
min-height: 50px;
|
13 |
+
word-wrap: break-word;
|
14 |
+
font-size: 0.9em;
|
15 |
+
color: blue;
|
16 |
+
}
|
17 |
+
</style><style type="text/css">
|
18 |
+
table.tableClass { border: solid black;
|
19 |
+
border-top-width: 1;
|
20 |
+
border-right-width: 1;
|
21 |
+
border-bottom-width: 1;
|
22 |
+
border-left-width: 1;
|
23 |
+
table-layout:fixed;
|
24 |
+
}
|
25 |
+
table.innerTableClass { border: solid black;
|
26 |
+
border-top-width: 0;
|
27 |
+
border-right-width: 0;
|
28 |
+
border-bottom-width: 0;
|
29 |
+
border-left-width: 0;
|
30 |
+
table-layout:fixed;
|
31 |
+
}
|
32 |
+
table.collapsabletableClass {
|
33 |
+
border-collapse:collapse;
|
34 |
+
border-top-width: 0;
|
35 |
+
border-right-width: 0;
|
36 |
+
border-bottom-width: 0;
|
37 |
+
border-left-width: 0;
|
38 |
+
table-layout:fixed;
|
39 |
+
}
|
40 |
+
th.tableClassLeft { border: solid black;
|
41 |
+
border-top-width: 0px;
|
42 |
+
border-right-width: 0px;
|
43 |
+
border-bottom-width: 1px;
|
44 |
+
border-left-width: 1px;
|
45 |
+
padding: 2px;
|
46 |
+
}
|
47 |
+
th.tableClassRight { border: solid black;
|
48 |
+
border-top-width: 0px;
|
49 |
+
border-right-width: 1px;
|
50 |
+
border-bottom-width: 1px;
|
51 |
+
border-left-width: 0;
|
52 |
+
padding: 2px;
|
53 |
+
}
|
54 |
+
th.tableClass { border: solid black;
|
55 |
+
border-top-width: 0px;
|
56 |
+
border-right-width: 1px;
|
57 |
+
border-bottom-width: 1px;
|
58 |
+
border-left-width: 1px;
|
59 |
+
padding: 2px;
|
60 |
+
}
|
61 |
+
td.tableClassLeft { border: solid black;
|
62 |
+
border-top-width: 0px;
|
63 |
+
border-right-width: 0px;
|
64 |
+
border-bottom-width: 1px;
|
65 |
+
border-left-width: 1px;
|
66 |
+
font-size: 0.9em;
|
67 |
+
color: blue;
|
68 |
+
word-wrap: break-word;
|
69 |
+
}
|
70 |
+
td.tableClassRight { border: solid black;
|
71 |
+
border-top-width: 0px;
|
72 |
+
border-right-width: 1px;
|
73 |
+
border-bottom-width: 1px;
|
74 |
+
border-left-width: 0;
|
75 |
+
font-size: 0.9em;
|
76 |
+
color: blue;
|
77 |
+
word-wrap: break-word;
|
78 |
+
}
|
79 |
+
td.tableClass { border: solid black;
|
80 |
+
border-top-width: 0px;
|
81 |
+
border-right-width: 1px;
|
82 |
+
border-bottom-width: 1px;
|
83 |
+
border-left-width: 1px;
|
84 |
+
font-size: 0.9em;
|
85 |
+
font-weight:bold;
|
86 |
+
color: black;
|
87 |
+
word-wrap: break-word;
|
88 |
+
}
|
89 |
+
td.tableClassNoBorder { border: solid black;
|
90 |
+
border-top-width: 0px;
|
91 |
+
border-right-width: 0px;
|
92 |
+
border-bottom-width: 0px;
|
93 |
+
border-left-width: 0px;
|
94 |
+
font-size: 0.9em;
|
95 |
+
font-weight:bold;
|
96 |
+
color: black;
|
97 |
+
word-wrap: break-word;
|
98 |
+
}
|
99 |
+
|
100 |
+
td.tableClassNoBorderBlue { border: solid black;
|
101 |
+
border-top-width: 0px;
|
102 |
+
border-right-width: 0px;
|
103 |
+
border-bottom-width: 0px;
|
104 |
+
border-left-width: 0px;
|
105 |
+
font-size: 0.9em;
|
106 |
+
font-weight:bold;
|
107 |
+
color: blue;
|
108 |
+
word-wrap: break-word;
|
109 |
+
}
|
110 |
+
|
111 |
+
td.tableClassInnerNoBorderBlue { border: solid black;
|
112 |
+
border-top-width: 0px;
|
113 |
+
border-right-width: 0px;
|
114 |
+
border-bottom-width: 0px;
|
115 |
+
border-left-width: 0px;
|
116 |
+
font-size: 1.4em;
|
117 |
+
font-weight:bold;
|
118 |
+
color: blue;
|
119 |
+
word-wrap: break-word;
|
120 |
+
}
|
121 |
+
|
122 |
+
td.tableClassNoBorderAlignLeft { border: solid black;
|
123 |
+
border-top-width: 0px;
|
124 |
+
border-right-width: 0px;
|
125 |
+
border-bottom-width: 0px;
|
126 |
+
border-left-width: 0px;
|
127 |
+
font-size: 0.9em;
|
128 |
+
font-weight:bold;
|
129 |
+
text-align: left;
|
130 |
+
color: black;
|
131 |
+
word-wrap: break-word;
|
132 |
+
}
|
133 |
+
|
134 |
+
td.signature {
|
135 |
+
padding: 4px 8px;
|
136 |
+
}
|
137 |
+
|
138 |
+
td.tableClassInner { border: solid black;
|
139 |
+
border-top-width: 0px;
|
140 |
+
border-right-width: 1px;
|
141 |
+
border-bottom-width: 1px;
|
142 |
+
border-left-width: 1px;
|
143 |
+
font-size: 1em;
|
144 |
+
font-weight:bold;
|
145 |
+
color: black;
|
146 |
+
word-wrap: break-word;
|
147 |
+
}
|
148 |
+
|
149 |
+
td.tableClassValign { border: solid black;
|
150 |
+
border-top-width: 0px;
|
151 |
+
border-right-width: 1px;
|
152 |
+
border-bottom-width: 1px;
|
153 |
+
border-left-width: 1px;
|
154 |
+
font-size: 0.9em;
|
155 |
+
font-weight:bold;
|
156 |
+
color: black;
|
157 |
+
vertical-align: middle;
|
158 |
+
text-align: center;
|
159 |
+
word-wrap: break-word;
|
160 |
+
}
|
161 |
+
|
162 |
+
td.tableClassValignNoBorder { border: solid black;
|
163 |
+
border-top-width: 0px;
|
164 |
+
border-right-width: 0px;
|
165 |
+
border-bottom-width: 0px;
|
166 |
+
border-left-width: 0px;
|
167 |
+
font-size: 0.9em;
|
168 |
+
font-weight:bold;
|
169 |
+
color: black;
|
170 |
+
vertical-align: middle;
|
171 |
+
text-align: center;
|
172 |
+
word-wrap: break-word;
|
173 |
+
}
|
174 |
+
|
175 |
+
td.tableClassValignInner { border: solid black;
|
176 |
+
border-top-width: 0px;
|
177 |
+
border-right-width: 1px;
|
178 |
+
border-bottom-width: 1px;
|
179 |
+
border-left-width: 1px;
|
180 |
+
font-size: 1em;
|
181 |
+
font-weight:bold;
|
182 |
+
color: black;
|
183 |
+
vertical-align: middle;
|
184 |
+
text-align: center;
|
185 |
+
word-wrap: break-word;
|
186 |
+
}
|
187 |
+
|
188 |
+
td.innerTableClassRightValign { border: solid black;
|
189 |
+
border-top-width: 0px;
|
190 |
+
border-right-width: 1px;
|
191 |
+
border-bottom-width: 1px;
|
192 |
+
border-left-width: 0;
|
193 |
+
font-size: 1em;
|
194 |
+
font-weight:bold;
|
195 |
+
color: black;
|
196 |
+
vertical-align: middle;
|
197 |
+
text-align: center;
|
198 |
+
word-wrap: break-word;
|
199 |
+
}
|
200 |
+
|
201 |
+
td.innerTableClassRightValignBottomLess { border: solid black;
|
202 |
+
border-top-width: 0px;
|
203 |
+
border-right-width: 1px;
|
204 |
+
border-bottom-width: 0px;
|
205 |
+
border-left-width: 0;
|
206 |
+
font-size: 1em;
|
207 |
+
font-weight:bold;
|
208 |
+
color: black;
|
209 |
+
vertical-align: middle;
|
210 |
+
text-align: center;
|
211 |
+
word-wrap: break-word;
|
212 |
+
}
|
213 |
+
|
214 |
+
td.tableClassInnerLeft { border: solid black;
|
215 |
+
border-top-width: 0px;
|
216 |
+
border-right-width: 0px;
|
217 |
+
border-bottom-width: 1px;
|
218 |
+
border-left-width: 1px;
|
219 |
+
font-size: 1em;
|
220 |
+
font-weight:bold;
|
221 |
+
color: black;
|
222 |
+
word-wrap: break-word;
|
223 |
+
}
|
224 |
+
|
225 |
+
td.tableClassInnerLeftBottomLess { border: solid black;
|
226 |
+
border-top-width: 0px;
|
227 |
+
border-right-width: 0px;
|
228 |
+
border-bottom-width: 0px;
|
229 |
+
border-left-width: 1px;
|
230 |
+
font-size: 1em;
|
231 |
+
font-weight:bold;
|
232 |
+
color: black;
|
233 |
+
word-wrap: break-word;
|
234 |
+
}
|
235 |
+
|
236 |
+
td.tableClassNoBorderAlignCenter { border: solid black;
|
237 |
+
border-top-width: 0px;
|
238 |
+
border-right-width: 0px;
|
239 |
+
border-bottom-width: 0px;
|
240 |
+
border-left-width: 0px;
|
241 |
+
font-size: 0.9em;
|
242 |
+
font-weight:bold;
|
243 |
+
color: black;
|
244 |
+
text-align: center;
|
245 |
+
word-wrap: break-word;
|
246 |
+
}
|
247 |
+
|
248 |
+
tr.tableClass { border: solid black;
|
249 |
+
border-top-width: 1px;
|
250 |
+
border-right-width: 1px;
|
251 |
+
border-bottom-width: 1px;
|
252 |
+
border-left-width: 1px;
|
253 |
+
}
|
254 |
+
tr.tableClassWithBg { border: solid black;
|
255 |
+
border-top-width: 0;
|
256 |
+
border-right-width: 1;
|
257 |
+
border-bottom-width: 1;
|
258 |
+
border-left-width: 0;
|
259 |
+
background-color: #e0e0ff
|
260 |
+
}
|
261 |
+
|
262 |
+
tr.tableClassWithBgBlack { border: solid black;
|
263 |
+
border-top-width: 0;
|
264 |
+
border-right-width: 1;
|
265 |
+
border-bottom-width: 1;
|
266 |
+
border-left-width: 0;
|
267 |
+
background-color: #D3D3D3
|
268 |
+
}
|
269 |
+
|
270 |
+
hr.header {
|
271 |
+
position: relative;
|
272 |
+
top: 20px;
|
273 |
+
border: none;
|
274 |
+
height: 6px;
|
275 |
+
background: black;
|
276 |
+
margin-bottom: 10px;
|
277 |
+
}
|
278 |
+
|
279 |
+
hr.separatorThin {
|
280 |
+
position: relative;
|
281 |
+
top: 2px;
|
282 |
+
border: none;
|
283 |
+
height: 2px;
|
284 |
+
background: black;
|
285 |
+
margin-bottom: 2px;
|
286 |
+
}
|
287 |
+
|
288 |
+
hr.headerThin {
|
289 |
+
position: relative;
|
290 |
+
top: 10px;
|
291 |
+
border: none;
|
292 |
+
height: 2px;
|
293 |
+
background: black;
|
294 |
+
margin-bottom: 10px;
|
295 |
+
}
|
296 |
+
|
297 |
+
hr.separator {
|
298 |
+
position: relative;
|
299 |
+
top: 20px;
|
300 |
+
border: none;
|
301 |
+
height: 4px;
|
302 |
+
background: black;
|
303 |
+
margin-bottom: 5px;
|
304 |
+
}
|
305 |
+
|
306 |
+
div.text {
|
307 |
+
background-color: #ffffff;
|
308 |
+
color: blue;
|
309 |
+
font-size: 1em;
|
310 |
+
font-weight:normal;
|
311 |
+
text-align:justify;
|
312 |
+
}
|
313 |
+
|
314 |
+
div.largetext {
|
315 |
+
background-color: #ffffff;
|
316 |
+
color: blue;
|
317 |
+
font-size: 1em;
|
318 |
+
font-weight:normal;
|
319 |
+
text-align:justify;
|
320 |
+
white-space: pre-wrap;
|
321 |
+
}
|
322 |
+
|
323 |
+
|
324 |
+
div.information {
|
325 |
+
background-color: #ffffff;
|
326 |
+
color: black;
|
327 |
+
font-size: 1em;
|
328 |
+
font-weight:normal;
|
329 |
+
text-align:justify;
|
330 |
+
}
|
331 |
+
|
332 |
+
#scheader {
|
333 |
+
font-size: 0.9em;
|
334 |
+
border: 0px solid #404040;
|
335 |
+
border-spacing: 2px;
|
336 |
+
}
|
337 |
+
|
338 |
+
</style></head><body lang="en-US" text="#000000" bgcolor="#ffffff"><hr class="header"><br><hr class="headerThin"><div class="contentwrapper"><table role="presentation" id="scheader"><tr><td class="tableClassNoBorderAlignCenter" style="font-size:2em;">
|
339 |
+
SECURITIES AND EXCHANGE COMMISSION
|
340 |
+
<br>
|
341 |
+
Washington, D.C. 20549
|
342 |
+
</td></tr><tr><td class="tableClassNoBorderAlignCenter"><br><br><div style="font-size:1.5em;">
|
343 |
+
SCHEDULE 13G
|
344 |
+
</div><br><br></td></tr><tr><td class="tableClassNoBorderAlignCenter"><div style="font-size:1.2em;">
|
345 |
+
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
346 |
+
</div></td></tr><tr><td class="center"></td></tr><tr><td class="center"><div class="information" style="text-align:center; font-weight:bold; color:blue;">8X8 INC</div><div class="information" style="text-align:center; font-weight:bold;"><hr class="separatorThin">(Name of Issuer)</div><br><br></td></tr><tr><td class="center"><div class="information" style="text-align:center; font-weight:bold; color:blue;">Common Stock</div><div class="information" style="text-align:center; font-weight:bold;"><hr class="separatorThin">(Title of Class of Securities)</div><br><br></td></tr><tr><td class="center"><div class="information" style="text-align:center; font-weight:bold; color:blue;">282914100</div><div class="information" style="text-align:center; font-weight:bold;"><hr class="separatorThin">(CUSIP Number)</div><br><br></td></tr><tr><td class="center"><div class="information" style="text-align:center; font-weight:bold; color:blue;">12/31/2024</div><div class="information" style="text-align:center; font-weight:bold;"><hr class="separatorThin">(Date of Event Which Requires Filing of this Statement)</div></td></tr></table><br><br><table><tr><td class="label"> Check the appropriate box to designate the rule pursuant to which this Schedule is filed:</td></tr><tr><td><img src="/Images/box-checked.jpg" alt="Checkbox checked"> Rule 13d-1(b)
|
347 |
+
</td></tr><tr><td><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"> Rule 13d-1(c)
|
348 |
+
</td></tr><tr><td><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"> Rule 13d-1(d)
|
349 |
+
</td></tr></table></div><hr class="headerThin"><hr class="header"><br><br>
|
350 |
+
<div class="content"><div class="form1"></div></div>
|
351 |
+
<div class="content"><div class="form1"><table><tr><td class="center"><br><br><p><div align="center" style="font-size:1.2em;">
|
352 |
+
SCHEDULE 13G
|
353 |
+
</div></p></td></tr></table><table role="presentation" class="tableClass" id="cusipNumber"><tr class="tableClass"><td width="25%" style="font-weight:bold;">CUSIP No.</td><td width="75%"><div style="font-size:.9em; color:#000000">282914100</div></td></tr></table><br><br><table role="presentation" class="tableClass" id="reportingPersonDetails"><tr class="tableClass"><td width="8%" class="tableClassValign">1</td><td width="92%" class="tableClass">Names of Reporting Persons
|
354 |
+
<br><br><div class="text">Boston Partners</div></td></tr><tr><td width="8%" class="tableClassValign">2</td><td width="92%" class="tableClass">Check the appropriate box if a member of a Group (see instructions)
|
355 |
+
<br><br><div class="text"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"> (a)
|
356 |
+
<br><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"> (b)
|
357 |
+
</div></td></tr><tr class="tableClassWithBgBlack"><td width="8%" class="tableClassValign">3</td><td width="92%" class="tableClass">Sec Use Only</td></tr><tr><td width="8%" class="tableClassValign">4</td><td width="92%" class="tableClass">Citizenship or Place of Organization
|
358 |
+
<br><br><div class="text">
|
359 |
+
DELAWARE
|
360 |
+
</div></td></tr><tr><td width="8%" class="tableClassValign">Number of Shares Beneficially Owned by Each Reporting Person With:</td><td width="92%" class="tableClass"><table class="innerTableClass"><tr><td width="8%" class="innerTableClassRightValign">5</td><td width="92%" class="tableClassInnerLeft">Sole Voting Power
|
361 |
+
<br><br><div class="text">6,594,707.00</div></td></tr><tr><td width="8%" class="innerTableClassRightValign">6</td><td width="92%" class="tableClassInnerLeft">Shared Voting Power
|
362 |
+
<br><br><div class="text">0.00</div></td></tr><tr><td width="8%" class="innerTableClassRightValign">7</td><td width="92%" class="tableClassInnerLeft">Sole Dispositive Power
|
363 |
+
<br><br><div class="text">6,594,707.00</div></td></tr><tr><td width="8%" class="innerTableClassRightValignBottomLess">8</td><td width="92%" class="tableClassInnerLeftBottomLess">Shared Dispositive Power
|
364 |
+
<br><br><div class="text">0.00</div></td></tr></table></td></tr><tr><td width="8%" class="tableClassValign">9</td><td width="92%" class="tableClass">Aggregate Amount Beneficially Owned by Each Reporting Person
|
365 |
+
<br><br><div class="text">6,594,707.00</div></td></tr><tr><td width="8%" class="tableClassValign">10</td><td width="92%" class="tableClass">Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
|
366 |
+
<br><br><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"></td></tr><tr><td width="8%" class="tableClassValign">11</td><td width="92%" class="tableClass">Percent of class represented by amount in row (9)
|
367 |
+
<br><br><div class="text">5.05 % </div></td></tr><tr><td width="8%" class="tableClassValign">12</td><td width="92%" class="tableClass">Type of Reporting Person (See Instructions)
|
368 |
+
<br><br><div class="text">IA</div></td></tr></table></div><div class="form1"><table><tr><td class="center"><br><br><p><div align="center" style="font-size:1.2em;">
|
369 |
+
SCHEDULE 13G
|
370 |
+
</div></p></td></tr></table><table role="presentation" id="item1to9"><tr><td width="8%" class="tableClassValignNoBorder">Item 1.</td><td width="92%" class="tableClassNoBorder"> </td></tr><tr class="tableClass"><td width="8%" class="tableClassNoBorderAlignCenter">(a)</td><td width="92%" class="tableClassNoBorder">Name of issuer:
|
371 |
+
<br><br><div class="text">8X8 INC</div></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(b)</td><td width="92%" class="tableClassNoBorder">Address of issuer's principal executive offices:
|
372 |
+
<br><br><div class="text">675 CREEKSIDE WAY
|
373 |
+
CAMPBELL, CALIFORNIA
|
374 |
+
95008</div></td></tr><tr><td width="8%" class="tableClassValignNoBorder">Item 2.</td><td width="92%" class="tableClassNoBorder"> </td></tr><tr class="tableClass"><td width="8%" class="tableClassNoBorderAlignCenter">(a)</td><td width="92%" class="tableClassNoBorder">Name of person filing:
|
375 |
+
<br><br><div class="largetext">Boston Partners</div></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(b)</td><td width="92%" class="tableClassNoBorder">Address or principal business office or, if none, residence:
|
376 |
+
<br><br><div class="largetext">ONE BEACON STREET
|
377 |
+
30TH FLOOR
|
378 |
+
BOSTON, Massachusetts
|
379 |
+
02108</div></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(c)</td><td width="92%" class="tableClassNoBorder">Citizenship:
|
380 |
+
<br><br><div class="largetext">Boston Partners - DELAWARE</div></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(d)</td><td width="92%" class="tableClassNoBorder">Title of class of securities:
|
381 |
+
<br><br><div class="text">Common Stock</div></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(e)</td><td width="92%" class="tableClassNoBorder">CUSIP No.:
|
382 |
+
<br><br><div class="text">282914100</div></td></tr><tr><td width="8%" class="tableClassValignNoBorder">Item 3.</td><td width="92%" class="tableClassNoBorder">If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(a)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"> Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
|
383 |
+
</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(b)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"> Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
|
384 |
+
</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(c)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"> Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
|
385 |
+
</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(d)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"> Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
|
386 |
+
</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(e)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-checked.jpg" alt="Checkbox checked"> An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
|
387 |
+
</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(f)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"> An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
|
388 |
+
</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(g)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"> A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
389 |
+
</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(h)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"> A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
390 |
+
</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(i)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"> A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
391 |
+
</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(j)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"> A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
|
392 |
+
<br> please specify the type of institution:
|
393 |
+
</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(k)</td><td width="92%" class="tableClassNoBorder"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"> Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
|
394 |
+
</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="100%" colspan="2" class="tableClassNoBorder"><div class="largetext"></div></td></tr><tr><td width="8%" class="tableClassValignNoBorder">Item 4.</td><td width="92%" class="tableClassNoBorder">Ownership</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(a)</td><td width="92%" class="tableClassNoBorder">Amount beneficially owned:
|
395 |
+
<br><br><div class="largetext">6,594,707</div></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(b)</td><td width="92%" class="tableClassNoBorder">Percent of class:
|
396 |
+
<br><br><div class="largetext">5.05 %
|
397 |
+
</div></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter">(c)</td><td width="92%" class="tableClassNoBorder">Number of shares as to which the person has:
|
398 |
+
<br></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder">(i) Sole power to vote or to direct the vote:
|
399 |
+
<br><br><div class="largetext">Boston Partners - 6,594,707</div><br></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder">(ii) Shared power to vote or to direct the vote:
|
400 |
+
<br><br><div class="largetext">Boston Partners - 0</div><br></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder">(iii) Sole power to dispose or to direct the disposition of:
|
401 |
+
<br><br><div class="largetext">Boston Partners - 6,594,707</div><br></td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder">(iv) Shared power to dispose or to direct the disposition of:
|
402 |
+
<br><br><div class="largetext">Boston Partners - 0</div><br></td></tr><tr><td width="8%" class="tableClassValignNoBorder">Item 5.</td><td width="92%" class="tableClassNoBorder">Ownership of 5 Percent or Less of a Class.</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder"><div class="text"></div></td></tr><tr><td width="8%" class="tableClassValignNoBorder">Item 6.</td><td width="92%" class="tableClassNoBorder">Ownership of more than 5 Percent on Behalf of Another Person.</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder"><div class="information" style="text-align:justify">
|
403 |
+
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
|
404 |
+
</div><br><br><div class="largetext">This Schedule is being filed with respect to 6,594,707.00 shares of 8X8, Inc. (the Common Stock) held by Boston Partners on 12/31/2024 for the discretionary account of certain clients. By reason of rule 13d-3 under the act Boston Partners may be deemed to be a beneficial owner of such Common Stock. To the knowledge of Boston Partners no person has the right to receive or the power to direct the receipt of dividends from or the proceeds from the sale of such Common Stock which represents more than 5% of the outstanding shares of the Common Stock referred to in item 4(b) hereof.</div></td></tr><tr><td width="8%" class="tableClassValignNoBorder">Item 7.</td><td width="92%" class="tableClassNoBorder">Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder"><div class="text">
|
405 |
+
Not Applicable
|
406 |
+
</div></td></tr><tr><td width="8%" class="tableClassValignNoBorder">Item 8.</td><td width="92%" class="tableClassNoBorder">Identification and Classification of Members of the Group.</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder"><div class="text">
|
407 |
+
Not Applicable
|
408 |
+
</div></td></tr><tr><td width="8%" class="tableClassValignNoBorder">Item 9.</td><td width="92%" class="tableClassNoBorder">Notice of Dissolution of Group.</td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder"><div class="text">
|
409 |
+
Not Applicable
|
410 |
+
</div></td></tr></table><br></div><div class="form1"><table role="presentation" id="certifications"><tr><td width="8%" class="tableClassValignNoBorder">Item 10.</td><td width="92%" class="tableClassNoBorder">Certifications:</td></tr><tr class="tableClass"><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder"><div class="largetext">By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</div></td></tr></table><br></div><div class="form1"><table role="presentation" id="signatureInfo"><tr><td width="8%" class="tableClassValignNoBorder"> SIGNATURE</td><td width="92%" class="tableClassNoBorder"> </td></tr><tr><td width="8%" class="tableClassNoBorderAlignCenter"> </td><td width="92%" class="tableClassNoBorder"><div class="information" style="text-align:justify">
|
411 |
+
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
412 |
+
<br><br></div></td></tr></table><table><tr class="tableClass"><td width="50%" class="tableClassNoBorder"> </td><td width="50%" class="tableClassNoBorder"><table><tr class="tableClass"><td width="100%" class="tableClassInnerNoBorderBlue"><div class="text">Boston Partners</div></td></tr></table></td></tr></table><table><tr class="tableClass"><td width="50%" class="tableClassNoBorder"> </td><td width="50%" class="tableClassNoBorder"><table><tr class="tableClass"><td width="8%" class="tableClassNoBorderAlignLeft signature">Signature:</td><td width="92%" class="tableClassNoBorderBlue signature">/s/ Akiko Lindholm</td></tr><tr class="tableClass"><td width="8%" class="tableClassNoBorderAlignLeft signature">Name/Title:</td><td width="92%" class="tableClassNoBorderBlue signature">Akiko Lindholm / Senior Compliance Manager</td></tr><tr class="tableClass"><td width="8%" class="tableClassNoBorderAlignLeft signature">Date:</td><td width="92%" class="tableClassNoBorderBlue signature">02/14/2025</td></tr></table></td></tr></table></div></div>
|
413 |
+
</body></html>
|
downloads_2025_onwards_2/1023731_2025-02-14_8X8_INC_DE_SCHEDULE_13G/1023731_2025-02-14_8X8_INC_DE_SCHEDULE_13G_primary_doc.pdf
ADDED
Binary file (38.3 kB). View file
|
|
downloads_2025_onwards_2/1023731_2025-02-14_8X8_INC_DE_SCHEDULE_13G/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards_2/1023731_2025-02-14_8X8_INC_DE_SCHEDULE_13G/images/page_2.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards_2/1023731_2025-02-14_8X8_INC_DE_SCHEDULE_13G/images/page_3.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards_2/1023731_2025-02-18_8X8_INC_DE_4/1023731_2025-02-18_8X8_INC_DE_4_wk-form4_1739912930.html
ADDED
@@ -0,0 +1,290 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
|
2 |
+
<html>
|
3 |
+
<head>
|
4 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
|
5 |
+
<title>SEC FORM
|
6 |
+
4</title>
|
7 |
+
<style type="text/css">
|
8 |
+
.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
|
9 |
+
.FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
|
10 |
+
.FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
|
11 |
+
.SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
|
12 |
+
.FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
|
13 |
+
.FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
|
14 |
+
.FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
|
15 |
+
.FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
|
16 |
+
.FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
|
17 |
+
.FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
|
18 |
+
.FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
19 |
+
.FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
20 |
+
.SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
21 |
+
.SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
|
22 |
+
.SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
|
23 |
+
.MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
24 |
+
.FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
25 |
+
.FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
|
26 |
+
.FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
27 |
+
.FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
|
28 |
+
.SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif;
|
29 |
+
font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
|
30 |
+
.FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
31 |
+
.CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid; border-color: black:}
|
32 |
+
body {background: white;}
|
33 |
+
</style>
|
34 |
+
</head>
|
35 |
+
<body>SEC Form 4
|
36 |
+
<table width="100%" border="0" cellspacing="0" cellpadding="4">
|
37 |
+
<tr>
|
38 |
+
<td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 4</td>
|
39 |
+
<td rowspan="2" width="60%" valign="middle" align="center">
|
40 |
+
<span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span>
|
41 |
+
</td>
|
42 |
+
<td rowspan="2" width="20%" valign="top" align="center"><table width="100%" border="1" summary="OMB Approval Status Box">
|
43 |
+
<tr><td class="FormTextC">OMB APPROVAL</td></tr>
|
44 |
+
<tr><td><table width="100%" border="0" summary="OMB Interior Box">
|
45 |
+
<tr>
|
46 |
+
<td class="SmallFormText" colspan="3">OMB Number:</td>
|
47 |
+
<td class="SmallFormTextR">3235-0287</td>
|
48 |
+
</tr>
|
49 |
+
<tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr>
|
50 |
+
<tr>
|
51 |
+
<td class="SmallFormText" colspan="3">hours per response:</td>
|
52 |
+
<td class="SmallFormTextR">0.5</td>
|
53 |
+
</tr>
|
54 |
+
</table></td></tr>
|
55 |
+
</table></td>
|
56 |
+
</tr>
|
57 |
+
<tr valign="middle">
|
58 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td> </td></tr></table></td>
|
59 |
+
<td class="SmallFormText">Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
|
60 |
+
<i>See</i>
|
61 |
+
|
62 |
+
Instruction 1(b).</td>
|
63 |
+
</tr>
|
64 |
+
<tr valign="middle">
|
65 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td> </td></tr></table></td>
|
66 |
+
<td class="SmallFormText">Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. </td>
|
67 |
+
</tr>
|
68 |
+
</table>
|
69 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
70 |
+
<tr>
|
71 |
+
<td rowspan="4" width="35%" valign="top">
|
72 |
+
<span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001956914">Kraus Kevin</a></td></tr></table>
|
73 |
+
<hr width="98%">
|
74 |
+
<table border="0" width="100%"><tr>
|
75 |
+
<td width="33%" class="MedSmallFormText">(Last)</td>
|
76 |
+
<td width="33%" class="MedSmallFormText">(First)</td>
|
77 |
+
<td width="33%" class="MedSmallFormText">(Middle)</td>
|
78 |
+
</tr></table>
|
79 |
+
<table border="0" width="100%">
|
80 |
+
<tr><td><span class="FormData">C/O 8X8 INC 675 CREEKSIDE WAY</span></td></tr>
|
81 |
+
<tr><td><span class="FormData"></span></td></tr>
|
82 |
+
</table>
|
83 |
+
<hr width="98%">
|
84 |
+
<span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr>
|
85 |
+
<td width="33%"><span class="FormData">CAMPBELL</span></td>
|
86 |
+
<td width="33%"><span class="FormData">CA</span></td>
|
87 |
+
<td width="33%"><span class="FormData">95008</span></td>
|
88 |
+
</tr></table>
|
89 |
+
<hr width="98%">
|
90 |
+
<table border="0" width="100%"><tr>
|
91 |
+
<td width="33%" class="MedSmallFormText">(City)</td>
|
92 |
+
<td width="33%" class="MedSmallFormText">(State)</td>
|
93 |
+
<td width="33%" class="MedSmallFormText">(Zip)</td>
|
94 |
+
</tr></table>
|
95 |
+
</td>
|
96 |
+
<td width="35%" valign="top">
|
97 |
+
<span class="MedSmallFormText">2. Issuer Name <b>and</b> Ticker or Trading Symbol
|
98 |
+
</span><br><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001023731">8X8 INC /DE/</a>
|
99 |
+
[ <span class="FormData">EGHT</span> ]
|
100 |
+
</td>
|
101 |
+
<td rowspan="2" valign="top">
|
102 |
+
<span class="MedSmallFormText">5. Relationship of Reporting Person(s) to Issuer
|
103 |
+
</span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%">
|
104 |
+
<tr>
|
105 |
+
<td width="15%" align="center"></td>
|
106 |
+
<td width="35%" class="MedSmallFormText">Director</td>
|
107 |
+
<td width="15%" align="center"></td>
|
108 |
+
<td width="35%" class="MedSmallFormText">10% Owner</td>
|
109 |
+
</tr>
|
110 |
+
<tr>
|
111 |
+
<td align="center"><span class="FormData">X</span></td>
|
112 |
+
<td class="MedSmallFormText">Officer (give title below)</td>
|
113 |
+
<td align="center"></td>
|
114 |
+
<td class="MedSmallFormText">Other (specify below)</td>
|
115 |
+
</tr>
|
116 |
+
<tr>
|
117 |
+
<td width="15%" align="center"></td>
|
118 |
+
<td width="35%" align="left" style="color: blue">Chief Financial Officer</td>
|
119 |
+
<td width="15%" align="center"></td>
|
120 |
+
<td width="35%" align="left" style="color: blue"></td>
|
121 |
+
</tr>
|
122 |
+
</table>
|
123 |
+
</td>
|
124 |
+
</tr>
|
125 |
+
<tr><td valign="top">
|
126 |
+
<span class="MedSmallFormText">3. Date of Earliest Transaction
|
127 |
+
(Month/Day/Year)</span><br><span class="FormData">02/15/2025</span>
|
128 |
+
</td></tr>
|
129 |
+
<tr>
|
130 |
+
<td valign="top">
|
131 |
+
<span class="MedSmallFormText">4. If Amendment, Date of Original Filed
|
132 |
+
(Month/Day/Year)</span><br>
|
133 |
+
</td>
|
134 |
+
<td valign="top">
|
135 |
+
<span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
|
136 |
+
</span><table border="0" width="100%">
|
137 |
+
<tr>
|
138 |
+
<td width="15%" align="center"><span class="FormData">X</span></td>
|
139 |
+
<td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td>
|
140 |
+
</tr>
|
141 |
+
<tr>
|
142 |
+
<td width="15%" align="center"></td>
|
143 |
+
<td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td>
|
144 |
+
</tr>
|
145 |
+
</table>
|
146 |
+
</td>
|
147 |
+
</tr>
|
148 |
+
</table>
|
149 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
150 |
+
<thead>
|
151 |
+
<tr><th width="100%" valign="top" colspan="11" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned</b></th></tr>
|
152 |
+
<tr>
|
153 |
+
<th width="36%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Security (Instr.
|
154 |
+
3)
|
155 |
+
</th>
|
156 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Transaction Date
|
157 |
+
(Month/Day/Year)</th>
|
158 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2A. Deemed Execution Date, if any
|
159 |
+
(Month/Day/Year)</th>
|
160 |
+
<th width="7%" valign="top" colspan="2" align="left" class="SmallFormText">3. Transaction Code (Instr.
|
161 |
+
8)
|
162 |
+
</th>
|
163 |
+
<th width="19%" valign="top" colspan="3" align="left" class="SmallFormText">4. Securities Acquired (A) or Disposed Of (D) (Instr.
|
164 |
+
3, 4 and 5)
|
165 |
+
</th>
|
166 |
+
<th width="11%" valign="top" rowspan="2" align="left" class="SmallFormText">5.
|
167 |
+
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
168 |
+
3 and 4)
|
169 |
+
</th>
|
170 |
+
<th width="9%" valign="top" rowspan="2" align="left" class="SmallFormText">6. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
171 |
+
4)
|
172 |
+
</th>
|
173 |
+
<th width="8%" valign="top" rowspan="2" align="left" class="SmallFormText">7. Nature of Indirect Beneficial Ownership (Instr.
|
174 |
+
4)
|
175 |
+
</th>
|
176 |
+
</tr>
|
177 |
+
<tr>
|
178 |
+
<th width="4%" align="center" class="SmallFormText">Code</th>
|
179 |
+
<th width="3%" align="center" class="SmallFormText">V</th>
|
180 |
+
<th width="8%" align="center" class="SmallFormText">Amount</th>
|
181 |
+
<th width="5%" align="center" class="SmallFormText">(A) or (D)</th>
|
182 |
+
<th width="6%" align="center" class="SmallFormText">Price</th>
|
183 |
+
</tr>
|
184 |
+
</thead>
|
185 |
+
<tbody><tr>
|
186 |
+
<td align="left"><span class="FormData">Common Stock</span></td>
|
187 |
+
<td align="center"><span class="FormData">02/15/2025</span></td>
|
188 |
+
<td align="center"></td>
|
189 |
+
<td align="center"><span class="SmallFormData">F</span></td>
|
190 |
+
<td align="center"></td>
|
191 |
+
<td align="center">
|
192 |
+
<span class="FormData">624</span><span class="FootnoteData"><sup>(1)</sup></span>
|
193 |
+
</td>
|
194 |
+
<td align="center"><span class="FormData">D</span></td>
|
195 |
+
<td align="center">
|
196 |
+
<span class="FormText">$</span><span class="FormData">3.12</span>
|
197 |
+
</td>
|
198 |
+
<td align="center"><span class="FormData">458,017</span></td>
|
199 |
+
<td align="center"><span class="FormData">D</span></td>
|
200 |
+
<td align="left"></td>
|
201 |
+
</tr></tbody>
|
202 |
+
</table>
|
203 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4"><thead>
|
204 |
+
<tr><th width="100%" valign="top" colspan="16" align="center" class="FormTextC">
|
205 |
+
<b>Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b>
|
206 |
+
</th></tr>
|
207 |
+
<tr>
|
208 |
+
<th width="13%" valign="top" rowspan="2" align="left" class="SmallFormText">1. Title of Derivative Security (Instr.
|
209 |
+
3)
|
210 |
+
</th>
|
211 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Conversion or Exercise Price of Derivative Security
|
212 |
+
</th>
|
213 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3. Transaction Date
|
214 |
+
(Month/Day/Year)</th>
|
215 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3A. Deemed Execution Date, if any
|
216 |
+
(Month/Day/Year)</th>
|
217 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">4. Transaction Code (Instr.
|
218 |
+
8)
|
219 |
+
</th>
|
220 |
+
<th width="10%" valign="top" colspan="2" align="left" class="SmallFormText">5.
|
221 |
+
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
|
222 |
+
3, 4 and 5)
|
223 |
+
</th>
|
224 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">6. Date Exercisable and Expiration Date
|
225 |
+
(Month/Day/Year)</th>
|
226 |
+
<th width="17%" valign="top" colspan="2" align="left" class="SmallFormText">7. Title and Amount of Securities Underlying Derivative Security (Instr.
|
227 |
+
3 and 4)
|
228 |
+
</th>
|
229 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">8. Price of Derivative Security (Instr.
|
230 |
+
5)
|
231 |
+
</th>
|
232 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">9.
|
233 |
+
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
234 |
+
4)
|
235 |
+
</th>
|
236 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">10. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
237 |
+
4)
|
238 |
+
</th>
|
239 |
+
<th width="7%" valign="top" rowspan="2" align="left" class="SmallFormText">11. Nature of Indirect Beneficial Ownership (Instr.
|
240 |
+
4)
|
241 |
+
</th>
|
242 |
+
</tr>
|
243 |
+
<tr>
|
244 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Code</th>
|
245 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">V</th>
|
246 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(A)</th>
|
247 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(D)</th>
|
248 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">Date Exercisable</th>
|
249 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Expiration Date</th>
|
250 |
+
<th width="10%" valign="bottom" align="center" class="SmallFormText">Title</th>
|
251 |
+
<th width="7%" valign="bottom" align="center" class="SmallFormText">Amount or Number of Shares</th>
|
252 |
+
</tr>
|
253 |
+
</thead></table>
|
254 |
+
<table border="0" width="100%">
|
255 |
+
<tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr>
|
256 |
+
<tr><td class="FootnoteData">1. Payment of tax liability by withholding securities incident to vesting of restricted stock units.</td></tr>
|
257 |
+
<tr><td class="FormText"><b>Remarks:</b></td></tr>
|
258 |
+
<tr><td class="FootnoteData"></td></tr>
|
259 |
+
</table>
|
260 |
+
<table width="100%" border="0">
|
261 |
+
<tr>
|
262 |
+
<td width="60%"></td>
|
263 |
+
<td width="20%"><u><span class="FormData">/s/ Cheriese Dickman Attorney-in-Fact for Kevin Kraus</span></u></td>
|
264 |
+
<td width="20%"><u><span class="FormData">02/18/2025</span></u></td>
|
265 |
+
</tr>
|
266 |
+
<tr>
|
267 |
+
<td></td>
|
268 |
+
<td class="MedSmallFormText">** Signature of Reporting Person</td>
|
269 |
+
<td class="MedSmallFormText">Date</td>
|
270 |
+
</tr>
|
271 |
+
<tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>
|
272 |
+
<tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person,
|
273 |
+
<i>see</i>
|
274 |
+
|
275 |
+
Instruction
|
276 |
+
4
|
277 |
+
|
278 |
+
(b)(v).</td></tr>
|
279 |
+
<tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
|
280 |
+
<i>See</i>
|
281 |
+
|
282 |
+
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>
|
283 |
+
<tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
|
284 |
+
<i>see</i>
|
285 |
+
|
286 |
+
Instruction 6 for procedure.</td></tr>
|
287 |
+
<tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>
|
288 |
+
</table>
|
289 |
+
</body>
|
290 |
+
</html>
|
downloads_2025_onwards_2/1023731_2025-02-18_8X8_INC_DE_4/1023731_2025-02-18_8X8_INC_DE_4_wk-form4_1739912930.pdf
ADDED
Binary file (46.9 kB). View file
|
|
downloads_2025_onwards_2/1023731_2025-02-18_8X8_INC_DE_4/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards_2/1023731_2025-02-20_8X8_INC_DE_4/1023731_2025-02-20_8X8_INC_DE_4_wk-form4_1740086507.html
ADDED
@@ -0,0 +1,287 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
|
2 |
+
<html>
|
3 |
+
<head>
|
4 |
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
|
5 |
+
<title>SEC FORM
|
6 |
+
4</title>
|
7 |
+
<style type="text/css">
|
8 |
+
.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
|
9 |
+
.FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
|
10 |
+
.FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
|
11 |
+
.SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
|
12 |
+
.FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
|
13 |
+
.FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
|
14 |
+
.FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
|
15 |
+
.FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
|
16 |
+
.FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
|
17 |
+
.FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
|
18 |
+
.FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
19 |
+
.FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
|
20 |
+
.SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
21 |
+
.SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
|
22 |
+
.SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
|
23 |
+
.MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
|
24 |
+
.FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
25 |
+
.FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
|
26 |
+
.FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
27 |
+
.FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
|
28 |
+
.SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif;
|
29 |
+
font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
|
30 |
+
.FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
|
31 |
+
.CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid; border-color: black:}
|
32 |
+
body {background: white;}
|
33 |
+
</style>
|
34 |
+
</head>
|
35 |
+
<body>SEC Form 4
|
36 |
+
<table width="100%" border="0" cellspacing="0" cellpadding="4">
|
37 |
+
<tr>
|
38 |
+
<td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 4</td>
|
39 |
+
<td rowspan="2" width="60%" valign="middle" align="center">
|
40 |
+
<span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span>
|
41 |
+
</td>
|
42 |
+
<td rowspan="2" width="20%" valign="top" align="center"><table width="100%" border="1" summary="OMB Approval Status Box">
|
43 |
+
<tr><td class="FormTextC">OMB APPROVAL</td></tr>
|
44 |
+
<tr><td><table width="100%" border="0" summary="OMB Interior Box">
|
45 |
+
<tr>
|
46 |
+
<td class="SmallFormText" colspan="3">OMB Number:</td>
|
47 |
+
<td class="SmallFormTextR">3235-0287</td>
|
48 |
+
</tr>
|
49 |
+
<tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr>
|
50 |
+
<tr>
|
51 |
+
<td class="SmallFormText" colspan="3">hours per response:</td>
|
52 |
+
<td class="SmallFormTextR">0.5</td>
|
53 |
+
</tr>
|
54 |
+
</table></td></tr>
|
55 |
+
</table></td>
|
56 |
+
</tr>
|
57 |
+
<tr valign="middle">
|
58 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td> </td></tr></table></td>
|
59 |
+
<td class="SmallFormText">Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
|
60 |
+
<i>See</i>
|
61 |
+
|
62 |
+
Instruction 1(b).</td>
|
63 |
+
</tr>
|
64 |
+
<tr valign="middle">
|
65 |
+
<td><table width="100%" border="1" cellpadding="0" cellspacing="0"><tr><td><span class="FormData">X</span></td></tr></table></td>
|
66 |
+
<td class="SmallFormText">Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. </td>
|
67 |
+
</tr>
|
68 |
+
</table>
|
69 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
70 |
+
<tr>
|
71 |
+
<td rowspan="4" width="35%" valign="top">
|
72 |
+
<span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001956914">Kraus Kevin</a></td></tr></table>
|
73 |
+
<hr width="98%">
|
74 |
+
<table border="0" width="100%"><tr>
|
75 |
+
<td width="33%" class="MedSmallFormText">(Last)</td>
|
76 |
+
<td width="33%" class="MedSmallFormText">(First)</td>
|
77 |
+
<td width="33%" class="MedSmallFormText">(Middle)</td>
|
78 |
+
</tr></table>
|
79 |
+
<table border="0" width="100%">
|
80 |
+
<tr><td><span class="FormData">C/O 8X8 INC 675 CREEKSIDE WAY</span></td></tr>
|
81 |
+
<tr><td><span class="FormData"></span></td></tr>
|
82 |
+
</table>
|
83 |
+
<hr width="98%">
|
84 |
+
<span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr>
|
85 |
+
<td width="33%"><span class="FormData">CAMPBELL</span></td>
|
86 |
+
<td width="33%"><span class="FormData">CA</span></td>
|
87 |
+
<td width="33%"><span class="FormData">95008</span></td>
|
88 |
+
</tr></table>
|
89 |
+
<hr width="98%">
|
90 |
+
<table border="0" width="100%"><tr>
|
91 |
+
<td width="33%" class="MedSmallFormText">(City)</td>
|
92 |
+
<td width="33%" class="MedSmallFormText">(State)</td>
|
93 |
+
<td width="33%" class="MedSmallFormText">(Zip)</td>
|
94 |
+
</tr></table>
|
95 |
+
</td>
|
96 |
+
<td width="35%" valign="top">
|
97 |
+
<span class="MedSmallFormText">2. Issuer Name <b>and</b> Ticker or Trading Symbol
|
98 |
+
</span><br><a href="/cgi-bin/browse-edgar?action=getcompany&CIK=0001023731">8X8 INC /DE/</a>
|
99 |
+
[ <span class="FormData">EGHT</span> ]
|
100 |
+
</td>
|
101 |
+
<td rowspan="2" valign="top">
|
102 |
+
<span class="MedSmallFormText">5. Relationship of Reporting Person(s) to Issuer
|
103 |
+
</span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%">
|
104 |
+
<tr>
|
105 |
+
<td width="15%" align="center"></td>
|
106 |
+
<td width="35%" class="MedSmallFormText">Director</td>
|
107 |
+
<td width="15%" align="center"></td>
|
108 |
+
<td width="35%" class="MedSmallFormText">10% Owner</td>
|
109 |
+
</tr>
|
110 |
+
<tr>
|
111 |
+
<td align="center"><span class="FormData">X</span></td>
|
112 |
+
<td class="MedSmallFormText">Officer (give title below)</td>
|
113 |
+
<td align="center"></td>
|
114 |
+
<td class="MedSmallFormText">Other (specify below)</td>
|
115 |
+
</tr>
|
116 |
+
<tr>
|
117 |
+
<td width="15%" align="center"></td>
|
118 |
+
<td width="35%" align="left" style="color: blue">Chief Financial Officer</td>
|
119 |
+
<td width="15%" align="center"></td>
|
120 |
+
<td width="35%" align="left" style="color: blue"></td>
|
121 |
+
</tr>
|
122 |
+
</table>
|
123 |
+
</td>
|
124 |
+
</tr>
|
125 |
+
<tr><td valign="top">
|
126 |
+
<span class="MedSmallFormText">3. Date of Earliest Transaction
|
127 |
+
(Month/Day/Year)</span><br><span class="FormData">02/18/2025</span>
|
128 |
+
</td></tr>
|
129 |
+
<tr>
|
130 |
+
<td valign="top">
|
131 |
+
<span class="MedSmallFormText">4. If Amendment, Date of Original Filed
|
132 |
+
(Month/Day/Year)</span><br>
|
133 |
+
</td>
|
134 |
+
<td valign="top">
|
135 |
+
<span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
|
136 |
+
</span><table border="0" width="100%">
|
137 |
+
<tr>
|
138 |
+
<td width="15%" align="center"><span class="FormData">X</span></td>
|
139 |
+
<td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td>
|
140 |
+
</tr>
|
141 |
+
<tr>
|
142 |
+
<td width="15%" align="center"></td>
|
143 |
+
<td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td>
|
144 |
+
</tr>
|
145 |
+
</table>
|
146 |
+
</td>
|
147 |
+
</tr>
|
148 |
+
</table>
|
149 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4">
|
150 |
+
<thead>
|
151 |
+
<tr><th width="100%" valign="top" colspan="11" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned</b></th></tr>
|
152 |
+
<tr>
|
153 |
+
<th width="36%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Security (Instr.
|
154 |
+
3)
|
155 |
+
</th>
|
156 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Transaction Date
|
157 |
+
(Month/Day/Year)</th>
|
158 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2A. Deemed Execution Date, if any
|
159 |
+
(Month/Day/Year)</th>
|
160 |
+
<th width="7%" valign="top" colspan="2" align="left" class="SmallFormText">3. Transaction Code (Instr.
|
161 |
+
8)
|
162 |
+
</th>
|
163 |
+
<th width="19%" valign="top" colspan="3" align="left" class="SmallFormText">4. Securities Acquired (A) or Disposed Of (D) (Instr.
|
164 |
+
3, 4 and 5)
|
165 |
+
</th>
|
166 |
+
<th width="11%" valign="top" rowspan="2" align="left" class="SmallFormText">5.
|
167 |
+
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
168 |
+
3 and 4)
|
169 |
+
</th>
|
170 |
+
<th width="9%" valign="top" rowspan="2" align="left" class="SmallFormText">6. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
171 |
+
4)
|
172 |
+
</th>
|
173 |
+
<th width="8%" valign="top" rowspan="2" align="left" class="SmallFormText">7. Nature of Indirect Beneficial Ownership (Instr.
|
174 |
+
4)
|
175 |
+
</th>
|
176 |
+
</tr>
|
177 |
+
<tr>
|
178 |
+
<th width="4%" align="center" class="SmallFormText">Code</th>
|
179 |
+
<th width="3%" align="center" class="SmallFormText">V</th>
|
180 |
+
<th width="8%" align="center" class="SmallFormText">Amount</th>
|
181 |
+
<th width="5%" align="center" class="SmallFormText">(A) or (D)</th>
|
182 |
+
<th width="6%" align="center" class="SmallFormText">Price</th>
|
183 |
+
</tr>
|
184 |
+
</thead>
|
185 |
+
<tbody><tr>
|
186 |
+
<td align="left"><span class="FormData">Common Stock</span></td>
|
187 |
+
<td align="center"><span class="FormData">02/18/2025</span></td>
|
188 |
+
<td align="center"></td>
|
189 |
+
<td align="center"><span class="SmallFormData">S</span></td>
|
190 |
+
<td align="center"></td>
|
191 |
+
<td align="center"><span class="FormData">1,000</span></td>
|
192 |
+
<td align="center"><span class="FormData">D</span></td>
|
193 |
+
<td align="center">
|
194 |
+
<span class="FormText">$</span><span class="FormData">3.34</span>
|
195 |
+
</td>
|
196 |
+
<td align="center"><span class="FormData">457,017</span></td>
|
197 |
+
<td align="center"><span class="FormData">D</span></td>
|
198 |
+
<td align="left"></td>
|
199 |
+
</tr></tbody>
|
200 |
+
</table>
|
201 |
+
<table width="100%" border="1" cellspacing="0" cellpadding="4"><thead>
|
202 |
+
<tr><th width="100%" valign="top" colspan="16" align="center" class="FormTextC">
|
203 |
+
<b>Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b>
|
204 |
+
</th></tr>
|
205 |
+
<tr>
|
206 |
+
<th width="13%" valign="top" rowspan="2" align="left" class="SmallFormText">1. Title of Derivative Security (Instr.
|
207 |
+
3)
|
208 |
+
</th>
|
209 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">2. Conversion or Exercise Price of Derivative Security
|
210 |
+
</th>
|
211 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3. Transaction Date
|
212 |
+
(Month/Day/Year)</th>
|
213 |
+
<th width="5%" valign="top" rowspan="2" align="left" class="SmallFormText">3A. Deemed Execution Date, if any
|
214 |
+
(Month/Day/Year)</th>
|
215 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">4. Transaction Code (Instr.
|
216 |
+
8)
|
217 |
+
</th>
|
218 |
+
<th width="10%" valign="top" colspan="2" align="left" class="SmallFormText">5.
|
219 |
+
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
|
220 |
+
3, 4 and 5)
|
221 |
+
</th>
|
222 |
+
<th width="9%" valign="top" colspan="2" align="left" class="SmallFormText">6. Date Exercisable and Expiration Date
|
223 |
+
(Month/Day/Year)</th>
|
224 |
+
<th width="17%" valign="top" colspan="2" align="left" class="SmallFormText">7. Title and Amount of Securities Underlying Derivative Security (Instr.
|
225 |
+
3 and 4)
|
226 |
+
</th>
|
227 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">8. Price of Derivative Security (Instr.
|
228 |
+
5)
|
229 |
+
</th>
|
230 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">9.
|
231 |
+
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
|
232 |
+
4)
|
233 |
+
</th>
|
234 |
+
<th width="6%" valign="top" rowspan="2" align="left" class="SmallFormText">10. Ownership Form: Direct (D) or Indirect (I) (Instr.
|
235 |
+
4)
|
236 |
+
</th>
|
237 |
+
<th width="7%" valign="top" rowspan="2" align="left" class="SmallFormText">11. Nature of Indirect Beneficial Ownership (Instr.
|
238 |
+
4)
|
239 |
+
</th>
|
240 |
+
</tr>
|
241 |
+
<tr>
|
242 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Code</th>
|
243 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">V</th>
|
244 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(A)</th>
|
245 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">(D)</th>
|
246 |
+
<th width="5%" valign="bottom" align="center" class="SmallFormText">Date Exercisable</th>
|
247 |
+
<th width="4%" valign="bottom" align="center" class="SmallFormText">Expiration Date</th>
|
248 |
+
<th width="10%" valign="bottom" align="center" class="SmallFormText">Title</th>
|
249 |
+
<th width="7%" valign="bottom" align="center" class="SmallFormText">Amount or Number of Shares</th>
|
250 |
+
</tr>
|
251 |
+
</thead></table>
|
252 |
+
<table border="0" width="100%">
|
253 |
+
<tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr>
|
254 |
+
<tr><td class="FormText"><b>Remarks:</b></td></tr>
|
255 |
+
<tr><td class="FootnoteData"></td></tr>
|
256 |
+
</table>
|
257 |
+
<table width="100%" border="0">
|
258 |
+
<tr>
|
259 |
+
<td width="60%"></td>
|
260 |
+
<td width="20%"><u><span class="FormData">/s/ Cheriese Dickman Attorney-in-Fact for Kevin Kraus</span></u></td>
|
261 |
+
<td width="20%"><u><span class="FormData">02/20/2025</span></u></td>
|
262 |
+
</tr>
|
263 |
+
<tr>
|
264 |
+
<td></td>
|
265 |
+
<td class="MedSmallFormText">** Signature of Reporting Person</td>
|
266 |
+
<td class="MedSmallFormText">Date</td>
|
267 |
+
</tr>
|
268 |
+
<tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>
|
269 |
+
<tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person,
|
270 |
+
<i>see</i>
|
271 |
+
|
272 |
+
Instruction
|
273 |
+
4
|
274 |
+
|
275 |
+
(b)(v).</td></tr>
|
276 |
+
<tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
|
277 |
+
<i>See</i>
|
278 |
+
|
279 |
+
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>
|
280 |
+
<tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
|
281 |
+
<i>see</i>
|
282 |
+
|
283 |
+
Instruction 6 for procedure.</td></tr>
|
284 |
+
<tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>
|
285 |
+
</table>
|
286 |
+
</body>
|
287 |
+
</html>
|
downloads_2025_onwards_2/1023731_2025-02-20_8X8_INC_DE_4/1023731_2025-02-20_8X8_INC_DE_4_wk-form4_1740086507.pdf
ADDED
Binary file (46 kB). View file
|
|
downloads_2025_onwards_2/1023731_2025-02-20_8X8_INC_DE_4/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards_2/1023731_2025-03-17_8X8_INC_DE_144/1023731_2025-03-17_8X8_INC_DE_144_primary_doc.html
ADDED
@@ -0,0 +1,140 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
|
2 |
+
<html xmlns:p="http://www.sec.gov/edgar/ownership" xmlns:p1="http://www.sec.gov/edgar/common"><head><meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1"><link rel="stylesheet" type="text/css" href="/css/SDR_print.css"><style type="text/css">
|
3 |
+
.fakeTextBox {
|
4 |
+
border-top: 2px solid #999;
|
5 |
+
border-right: 1px solid #ccc;
|
6 |
+
border-bottom: 1px solid #ccc;
|
7 |
+
border-left: 2px solid #999;
|
8 |
+
padding: 2px;
|
9 |
+
_width: 800px;
|
10 |
+
height: auto;
|
11 |
+
min-width: 200px;
|
12 |
+
min-height: 50px;
|
13 |
+
word-wrap: break-word;
|
14 |
+
font-size: 0.9em;
|
15 |
+
color: blue;
|
16 |
+
}
|
17 |
+
</style><style type="text/css">
|
18 |
+
table.tableClass { border: solid black;
|
19 |
+
border-top-width: 1;
|
20 |
+
border-right-width: 1;
|
21 |
+
border-bottom-width: 1;
|
22 |
+
border-left-width: 1;
|
23 |
+
table-layout:fixed;
|
24 |
+
}
|
25 |
+
th.tableClassLeft { border: solid black;
|
26 |
+
border-top-width: 0px;
|
27 |
+
border-right-width: 0px;
|
28 |
+
border-bottom-width: 1px;
|
29 |
+
border-left-width: 1px;
|
30 |
+
padding: 2px;
|
31 |
+
}
|
32 |
+
th.tableClassRight { border: solid black;
|
33 |
+
border-top-width: 0px;
|
34 |
+
border-right-width: 1px;
|
35 |
+
border-bottom-width: 1px;
|
36 |
+
border-left-width: 0;
|
37 |
+
padding: 2px;
|
38 |
+
}
|
39 |
+
th.tableClass { border: solid black;
|
40 |
+
border-top-width: 0px;
|
41 |
+
border-right-width: 1px;
|
42 |
+
border-bottom-width: 1px;
|
43 |
+
border-left-width: 1px;
|
44 |
+
padding: 2px;
|
45 |
+
}
|
46 |
+
td.tableClassLeft { border: solid black;
|
47 |
+
border-top-width: 0px;
|
48 |
+
border-right-width: 0px;
|
49 |
+
border-bottom-width: 1px;
|
50 |
+
border-left-width: 1px;
|
51 |
+
font-size: 0.9em;
|
52 |
+
color: blue;
|
53 |
+
word-wrap: break-word;
|
54 |
+
}
|
55 |
+
td.tableClassRight { border: solid black;
|
56 |
+
border-top-width: 0px;
|
57 |
+
border-right-width: 1px;
|
58 |
+
border-bottom-width: 1px;
|
59 |
+
border-left-width: 0;
|
60 |
+
font-size: 0.9em;
|
61 |
+
color: blue;
|
62 |
+
word-wrap: break-word;
|
63 |
+
}
|
64 |
+
td.tableClass { border: solid black;
|
65 |
+
border-top-width: 0px;
|
66 |
+
border-right-width: 1px;
|
67 |
+
border-bottom-width: 1px;
|
68 |
+
border-left-width: 1px;
|
69 |
+
font-size: 0.9em;
|
70 |
+
color: blue;
|
71 |
+
word-wrap: break-word;
|
72 |
+
}
|
73 |
+
tr.tableClass { border: solid black;
|
74 |
+
border-top-width: 1px;
|
75 |
+
border-right-width: 1px;
|
76 |
+
border-bottom-width: 1px;
|
77 |
+
border-left-width: 1px;
|
78 |
+
}
|
79 |
+
tr.tableClassWithBg { border: solid black;
|
80 |
+
border-top-width: 0;
|
81 |
+
border-right-width: 1;
|
82 |
+
border-bottom-width: 1;
|
83 |
+
border-left-width: 0;
|
84 |
+
background-color: #e0e0ff
|
85 |
+
}
|
86 |
+
</style></head><body lang="en-US" text="#000000" bgcolor="#ffffff">
|
87 |
+
<div class="contentwrapper"><table role="presentation" id="header"><tr><td class="title">Form 144 Filer Information</td><td rowspan="2" class="center">
|
88 |
+
UNITED STATES
|
89 |
+
<br>
|
90 |
+
SECURITIES AND EXCHANGE COMMISSION
|
91 |
+
<br>
|
92 |
+
Washington, D.C. 20549
|
93 |
+
<br><br>
|
94 |
+
Form 144
|
95 |
+
<br><br><div style="font-size:.9em;">
|
96 |
+
NOTICE OF PROPOSED SALE OF SECURITIES
|
97 |
+
<br>
|
98 |
+
PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
|
99 |
+
</div></td><td></td></tr><tr><td class="side" style="text-align: center;vertical-align:middle"><p>
|
100 |
+
FORM 144</p></td><td width="25%"></td></tr></table></div><div id="info"><div class="contentwrapper"><div class="content"><h1>144: Filer Information</h1><table role="presentation" class="filerInformation"><tr><td class="label">Filer CIK</td><td><div class="fakeBox">0001956914</div></td></tr><tr><td class="label">Filer CCC</td><td><div class="fakeBox">XXXXXXXX</div></td></tr><tr><td class="label">
|
101 |
+
Is this a LIVE or TEST Filing?
|
102 |
+
</td><td><img src="/Images/radio-checked.jpg" alt="Radio button checked"> LIVE
|
103 |
+
<img src="/Images/radio-unchecked.jpg" alt="Radio button not checked"> TEST
|
104 |
+
</td></tr><tr><td><h4><em>Submission Contact Information</em></h4></td></tr><tr><td class="label">Name</td><td><div class="fakeBox"></div></td></tr><tr><td class="label">Phone</td><td><div class="fakeBox"></div></td></tr><tr><td class="label">E-Mail Address</td><td><div class="fakeBox"></div></td></tr></table></div></div></div>
|
105 |
+
<div class="content"><h1>144: Issuer Information</h1><div class="form1"><table role="presentation" class="filingInformation" id="submissionInformation"><tr><td class="label">Name of Issuer</td><td><div class="fakeBox">8x8, INC.</div></td></tr><tr><td class="label">SEC File Number</td><td><div class="fakeBox">001-38312</div></td></tr><tr><td class="label">Address of Issuer</td><td><div class="fakeBox">675 Creekside Way <br>Campbell<br>
|
106 |
+
CALIFORNIA
|
107 |
+
<br>95008</div></td></tr><tr><td class="label">Phone</td><td><div class="fakeBox">4087271885</div></td></tr><tr><td class="label">Name of Person for Whose Account the Securities are To Be Sold</td><td><div class="fakeBox">KEVIN KRAUS</div></td></tr><tr><td colspan="2"><div class="information" style="text-align:justify">
|
108 |
+
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account
|
109 |
+
the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given
|
110 |
+
as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales
|
111 |
+
for the account of the person filing this notice.
|
112 |
+
<br><br></div></td></tr><tr><td class="label">Relationship to Issuer</td><td><div class="fakeBox">Officer</div></td></tr></table></div><h1>144: Securities Information</h1><div class="form1"><table role="presentation" class="tableClass" id="submissionInformation"><tr width="100%" class="tableClassWithBg"><th width="23%" class="tableClass">Title of the Class of Securities To Be Sold</th><th width="22%" class="tableClass">Name and Address of the Broker</th><th width="11%" class="tableClass">Number of Shares or Other Units To Be Sold</th><th width="12%" class="tableClass">Aggregate Market Value</th><th width="11%" class="tableClass">Number of Shares or Other Units Outstanding</th><th width="8%" class="tableClass">Approximate Date of Sale</th><th width="12%" class="tableClass">Name the Securities Exchange</th></tr><tr width="100%" class="tableClass"><td width="23%" class="tableClass">Common</td><td width="22%" class="tableClass"><div>Morgan Stanley Smith Barney LLC Executive Financial Services<br>1 New York Plaza<br>8th Floor<br>New York
|
113 |
+
�
|
114 |
+
NY
|
115 |
+
�
|
116 |
+
10004</div></td><td width="11%" class="tableClass">4000</td><td width="12%" class="tableClass">8560.00</td><td width="11%" class="tableClass">131693671</td><td width="8%" class="tableClass">03/17/2025</td><td width="12%" class="tableClass"><div>NASDAQ</div></td></tr></table></div><br><br><div class="information" style="text-align:justify">
|
117 |
+
Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment
|
118 |
+
of all or any part of the purchase price or other consideration therefor:
|
119 |
+
</div><h1>144: Securities To Be Sold</h1><div class="form1"><table role="presentation" class="tableClass" id="securitiesToBeSold"><tr width="100%" class="tableClassWithBg"><th width="14%" class="tableClassRight">Title of the Class</th><th width="8%" class="tableClass">Date you Acquired</th><th width="16%" class="tableClass">Nature of Acquisition Transaction</th><th width="14%" class="tableClass">Name of Person from Whom Acquired</th><th width="4%" class="tableClass">Is this a Gift?</th><th width="8%" class="tableClass">Date Donor Acquired</th><th width="12%" class="tableClass">Amount of Securities Acquired</th><th width="8%" class="tableClass">Date of Payment</th><th width="16%" class="tableClassLeft">Nature of Payment <b>*</b></th></tr><tr width="100%" class="tableClass"><td width="14%" class="tableClassRight">Common</td><td width="8%" class="tableClass">06/15/2024</td><td width="16%" class="tableClass">Restricted Stock Units</td><td width="14%" class="tableClass">Issuer</td><td width="4%" class="tableClass"><img src="/Images/box-unchecked.jpg" alt="Checkbox not checked"></td><td width="8%" class="tableClass"></td><td width="12%" class="tableClass">4000</td><td width="8%" class="tableClass">06/15/2024</td><td width="16%" class="tableClassLeft">N/A</td></tr></table><br><div class="information" style="text-align:justify"><b>*</b> If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note
|
120 |
+
thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made
|
121 |
+
in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.
|
122 |
+
</div><br></div><br><br><div class="information" style="text-align:justify">
|
123 |
+
Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.
|
124 |
+
</div><h1>144: Securities Sold During The Past 3 Months</h1><div class="form1"><table role="presentation" class="tableClass" id="submissionInformation"><tr width="100%" class="tableClassWithBg"><th width="33%" class="tableClass">Name and Address of Seller</th><th width="33%" class="tableClass">Title of Securities Sold</th><th width="8%" class="tableClass">Date of Sale</th><th width="12%" class="tableClass">Amount of Securities Sold</th><th width="14%" class="tableClass">Gross Proceeds</th></tr><tr><td width="33%" class="tableClass">10b5-1 Sales for KEVIN KRAUS<br>675 Creekside Way <br>Campbell
|
125 |
+
�
|
126 |
+
CA
|
127 |
+
�
|
128 |
+
95008</td><td width="33%" class="tableClass">Common</td><td width="8%" class="tableClass">02/18/2025</td><td width="12%" class="tableClass">1000</td><td width="14%" class="tableClass">3340.00</td></tr><tr><td width="33%" class="tableClass">10b5-1 Sales for KEVIN KRAUS<br>675 Creekside Way <br>Campbell
|
129 |
+
�
|
130 |
+
CA
|
131 |
+
�
|
132 |
+
95008</td><td width="33%" class="tableClass">Common</td><td width="8%" class="tableClass">01/15/2025</td><td width="12%" class="tableClass">1000</td><td width="14%" class="tableClass">2600.00</td></tr></table></div><h1>144: Remarks and Signature</h1><div class="form1"><table role="presentation" class="filingInformation" id="submissionInformation"><tr><td class="label">Remarks</td><td><div class="fakeBox"></div></td></tr><tr><td class="label">Date of Notice</td><td><div class="fakeBox">03/17/2025</div></td></tr><tr><td class="label">Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1</td><td><div class="fakeBox">08/12/2024</div></td></tr><tr><td colspan="2"><h4><em>ATTENTION:</em></h4></td></tr><tr><td colspan="2" style="text-align:justify">
|
133 |
+
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing
|
134 |
+
this notice that he does not know any material adverse information in regard to the current and prospective
|
135 |
+
operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has
|
136 |
+
adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by
|
137 |
+
signing the form and indicating the date that the plan was adopted or the instruction given, that person makes
|
138 |
+
such representation as of the plan adoption or instruction date.
|
139 |
+
</td></tr><tr><td class="label">Signature</td><td><div class="fakeBox">/s/ Kevin Kraus</div></td></tr><tr><td colspan="2"><h4 style="text-align:center"><em>ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)</em></h4></td></tr></table></div></div>
|
140 |
+
</body></html>
|
downloads_2025_onwards_2/1023731_2025-03-17_8X8_INC_DE_144/1023731_2025-03-17_8X8_INC_DE_144_primary_doc.pdf
ADDED
Binary file (34.2 kB). View file
|
|
downloads_2025_onwards_2/1023731_2025-03-17_8X8_INC_DE_144/images/page_1.png
ADDED
![]() |
Git LFS Details
|
downloads_2025_onwards_2/1023731_2025-03-17_8X8_INC_DE_144/images/page_2.png
ADDED
![]() |
Git LFS Details
|